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SUMMARY THESIS (ABSTRACT) 
 
Polycyclic aromatic hydrocarbons (PAHs) are a very large group of organic compounds 
made of carbon and hydrogen atoms. These compounds present an important impact as 
environmental pollutants. They are a primary concern for human health, as PAHs have 
been reported to increase the risk of cancer in humans. It is therefore of high importance 
to avail of a method to detect them in any matter that humans may get in contact with, 
such as food, soil and water. The European Drinking Water Directive (98/83/EC) 
recommends a value of 0.01ng/ml as a limit for Benzo[a]pyrene (BaP) levels in drinking 
water. Traditionally, detection of PAHs in the environment was done using commercial 
equipment such as HPLC-fluorescence detection and Gas Chromatography-Mass 
Spectrometry (GC-MS). However, these techniques are often expensive, use large 
amounts of toxic solvents, are time-consuming, and non-portable [8,9]. In this research, 
immunosensors were used for BaP determination in water sample. Immunosensors are 
affinity biosensors based on the specific interaction between antigens and antibodies; 
this interaction could be monitored by several techniques including electrochemistry. 
Voltammetric detection with the immunosensor provides an approach, which could be 
performed in small portable instrument for in-field measurements. Electrochemistry 
technique has several advantages compared to other techniques; it is easy to apply and 
also have the advantages of miniaturisation, portability, real measurement time, low-
cost production and fabrication without reducing their levels of detection or sensitivity. 
This thesis is to address the shortcomings of the current techniques. The study presented 
in this thesis described the development of the immunosensors with electrochemical 
detection for detection of polycyclic aromatic hydrocarbon in environmental monitoring 




This work shows how the integration of electrochemical techniques with an 
immunoassay method can reach limits of detection as low as required for the analysis of 
water samples in situ and in real time. In particular, we targeted to detect the presence of 
(BaP) in water. Results obtained by optical and electrochemical detections were 
validated with Gas Chromatography-Mass Spectrometry (GC-MS). The usage of this 
method as a complement to the electrochemical studies, not only increased the quality 
of the research, but also helped in the construction and improvement of immunosensors. 
They were not reliable, but also represent accurate characteristics to be employed in 
miniaturised sensor and fluidic system. This thesis is organized in six chapters and a 
brief explanation for each of them is shown below: 
Chapter 1 is a general introduction about the essential concepts and conditions used in 
this thesis. Chapter 2 offers an understanding of the key principles of optical 
immunoassay involved in this thesis. An optical immunoassay using a 96-well 
microtiter plate as a solid surface was developed. Chapter 3 the application of the 
developed electrochemical immunosensors was discussed. Chapter 4, focuses on the 
design, fabrication and characterization of a Q-sens (Lab On a Chip) that was developed 
for use in electrochemical application. Chapter 5 demonstrates the validation study in 
order to confirm that the applied developed method for a PAH was suitable for its 
intended use. The validation could compare the reliability and sensitivity of the 








The objective of the work presented is to develop an electrochemical sensing array to 
detect PAHs in the environment, as they represent a toxic threat for health in water and 
the current detection methods are time consuming and non-portable. 
Hypothesis: 
The research will focus on the integration of a sensor arrays with immunoassay and 
electrochemical detection methods. Water samples will be spiked with PAHs and tested 
using the immunosensor arrays. ELISA will be used to help validate the electrochemical 
analysis This project show the work done towards the optimisation of the immunoassay 
protocol for PAHs detection in water samples, and its transfer into a lab-on-a chip 
application that has a particular focus on environmental screening. 
Research strategy: 
The first year aim of the research was to optimize ELISA reagents and detection 
methods. The second year and first half of the third year of the research were for 
integrating the immunoassay method with lab on a chip platform. The second half of the 
third year was for the interfaces between lab on a chip platform and the bio recognition 
element modified with the addition of metal nanoparticle, magnetic beads. During the 
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1. General Introduction  
 
 Motivation  
Since their first appearance in 1962, biosensors have undergone gradual 
development, improvement and innovation. This advancement is attributed to 
their outstanding features and growth potential. Biosensors are a low cost 
option compared to other methods currently in use, such as the early 
immunoassays (ELISA). Integration of biosensors with lab-on-a chip 
platforms and their ability to perform environmental monitoring and testing 
demonstrates the significant opportunities that they offer when successfully 
integrated and properly implemented. There are many requirements for 
biosensors, in order to be cost- effective tools, they need to produce fast results 
and have a low-cost production. There are many challenges pertaining to 
environmental monitoring of pollutants, food analysis, and pharmaceutical 
development. However, despite these challenges, biosensors are already in 
use. The impact of biosensors on the quality of life can be important if the key 
limitations related to cost and some existing technical barriers are overcome.  
In addition, their commercial potential can be increased by reducing the cost 









1.1 Biosensors  
 According to the International Union of Pure and Applied Chemistry (IUPAC), a 
biosensor is defined as a self-contained and integrated receptor-transducer device, 
which provides selective quantitative or semi-quantitative analytical data using a 
bio-receptor and transducer to effect spatial contact. [2]. The Biosensor & 
Bioelectronics defines biosensors as analytical devices that incorporate biological 
material, such as tissue, antibodies, microorganisms, organelles, nucleic acids, cell 
receptors, and enzymes, and biologically derived materials or biomimic, which are 
linked with a physicochemical transducer. The transducer may be thermometric, 
magnetic, electrochemical, piezoelectric, optical or micromechanical [3]. Figure 1.1 
below depicts the principal parts of a biosensor. 
 
Figure 1.1: Schematic of different types of biosensor. The biocomponent is immobilised on a 
biocompatible layer, resulting in a change of physical or chemical properties of the elements that can 















1.1.1 Biosensing Components 
The two main types of recognition element within biosensing devices are affinity 
and catalytic. The affinity type constitutes antibodies and nucleic acids. The catalytic 
part consists of cells, enzymes, and tissues [4].  
1.1.1.1  Antibodies 
 Antibodies can be used to develop immunosensors. They use the immobilisation of 
antibodies (Abs) as a biological recognition component to detect the specific antigen. 
Figure 1.2 below shows schematic representation of an antibody’s Y-shape structure 
[5]. 
   
Figure 1.2: A general structure of an individual immune protein molecule 
 
In addition, immunosensors are mainly used in rapid detection methods, with the 
exception of glucose biosensors [6]. They use labelled antibodies or antigens, 
coupled with other compounds, to complete the recognition step. Transducers, such 
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as an electrochemical impedance spectroscopy (EIS) and a surface plasmon 
resonance (SPR), can work in different modes. Therefore, they may be used under a 
label-free detection mode. This detection mode may be modified to competitive, 
non-competitive and displacement assay formats, thereby eliminating the need to use 
label or chemical compounds, which may affect the sensitivity of the sensors [7]. 
1.1.1.2     Enzymes 
An enzyme is a protein that catalyses the chemical reaction in living system at 
significant rates. The ideal enzyme label has to be very high catalytic activity 
toward a specific substrate. Glucose oxidase [8] and urease [9] are some of the 
major enzymes utilised. In some instances, enzymes inside cells, such as bacterial 
cells can be used to detect atrazine [10].  
1.1.2 Bio-transducer Components 
A transducer is a tool that converts the biorecognition event into a detectable 
electronic signal [11]. Biosensors use different types of transducers, such as the 
electrochemical, optical acoustic and calorimetric transducers. Electrical 
transducers are commonly used, because they can be operated with little difficulty 
and contain rapid response immunosensors [12].  
1.1.2.1    Electrochemical Biosensors 
Electrochemical biosensors contain an electrochemical transducer and a 
transduction component. IUPAC defines an electrochemical biosensor a self-
contained integrated element, which gives analytical data using a biochemical 
receptor, which spatially contacts with an electrochemical transduction component. 
These types of biosensors are commonly used to measure the current yielded during 
oxidation and reduction reactions. At present, they are numbers of transducers that 
have been used in electrochemical detection including voltammetric, amperometric, 
5 
 
potentiometric and impedimetric. These are all used in the measurement of 
pollution in water. Biosensor electrodes play a significant role in the performance 
of electrochemical cells. An electrochemical analyser measures targets since it can 
measure current in each electrochemical cell. An electrochemical cell has three 
types of electrodes; the reference electrode (RE); the counter electrode (CE); and 
the working electrode (WE); the Table 1.1 below explains the three types. 
 








WE (cathodic or anodic) is where the electrically driven chemical 
reaction and electron transport take place. They represent the 
location where the electrochemical reactions take place (oxidative 
& reductive). WE selection also has two main aspects; the target 
analyte redox behaviour and the current in the background over 
the potential region, which is essential for measurement. Other 
WE selection features include; [electrochemical potential 
window, mechanical characteristics, accessibility, electrical 






RE produces a constant potential [15] such as Ag/AgCl. Low 
impedance and non-polarizable electrodes are suitable, because 
they prevent changing of the RE potential. In addition, high 
impedance not only heightens the susceptibility of the method to 









In an electrochemical cell, CE ensures that current does not run 
through the reference electrode, since such a flow would change 
the reference electrodes potential. It is made of inert materials; 
hence it does not participate in electrochemical reactions [16].      
It can be used together with WE to measure other variables. In 
this case, the WE acts as a cathode while the CE can be used as 
an anode.  
 
1.1.2.1.1 Electrochemical Techniques 
A. Amperometric Transducers 
This type of transducers measures currents resulting from an electrochemical 
reaction. They work upon the premise that current can only be produced in the 
process of bio-recognition of an electro-active species after the application of a 
steady potential on the working electrode. This potential can force the species to 
donate or accept electrons. The rate at which electron are transferred is represented 
by the current in order to complete the recognition process.   
B. Voltammetric Transducers  
Voltammetric transducers can be used to detect the current that is recorded as a 
function of the applied potential. Here the peak current is equivalent to a specific 
chemical and is directly related to the species concentration. Low noise, higher 
sensitivity, and detection of a variety of compounds with different peak potentials 
in one experiment are some of its benefits. Data concerning particular chemical 
reactions are acquired by plotting the current produced by the analyte at the 
potential applied to the working electrode [17].  
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• Linear Sweep Voltammetry (LSV)  
Linear sweep voltammetry is a widely use electrochemical technique that utilises 
the change in potential as a linear function of time. In tandem with the Nernst 
equation, linear sweep voltammetry can determine unknown species and 
concentration of electrolytic solutions. Figure 1.3 shows a sample linear sweep 
voltammogram when the potential is applied versus time. The slop can be applied 
to calculate the scan rate of the voltage.  The scan begins on the left at zero current. 
As the voltage increases, current also starts to flow reaching a peak before dropping 
as shown in Figure 1.3. Oxidation and reduction of species is reported as a peak and 








 Figure 1.3: A typical Linear Sweep Voltammetry. The slop shows the scan rate of the experiment   
(volts per unite time). 
 
• Cyclic Voltammetry (CV) 
It is an effective electrochemical technique widely used to examine the reduction 
and oxidation processes and study the performance of electrodes. It is also used in 
the characterization of electron transfers involving biofilms or microbial cells. The 
redox reaction caused by the working eletrode can be either of the individual steps 
depending on the system: the rate of mass transfer of the electroactive species, the 
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rate of absorption or desorption on the electrode surface, the rate of electron 
transfer between the electroactive species and the electrode, or the rate of individual 
chemical reactions. The electric potential and concentration of the species involved 
in the redox reaction can be described by the Nernst Equation in equation 1 (at 298 
K): 






                                Equation 1 
Where E is the applied potential, E^0the formal potential, n is the number of 
electrons gained in the reduction, [Ox] as the concentration of oxidized species and 
[Red] as the concentration of reduced species.  
C. Conductometric Transducers 
Conductometric transducer monitors the ionic concentration of a species, which 
leads to a change in electrical conductivity. It contains two electrodes and an AC 
voltage, which is employed through the electrodes.  An alteration in conductance 
between the electrodes occurs when the ionic composition changes. The technique 
does not require RE. They are, therefore, inexpensive and simple to miniaturise. 
The main disadvantage of conductometric transducer compared to amperometric 
and potentiometric transducers is their relatively lower sensitivity. [18]. 
D. Impedimetric Transducers 
This transducer recognises changes in impedance generated as a result of 
immobilising biomaterials on the electrodes causing a change in capacitance and 
the transfer of electrons between the electrodes. Electrochemical impedance 
spectroscopy (EIS), which is associated with this type of transducer, characterises 




E. Potentiometric Transducers 
In potentiometric transducer, a transmembrane potential is yielded by a biological 
detection reaction. Potentiometric biosensors are used to detect potential with 
regard to an identified electrode. A high impedance voltmeter is used to measure 
the potential. Based on the Nernst equation, this biosensor connects the electrode 
potential (E) of identified electrode depending on the concentration of oxidized or 
reduced species [20].  
1.1.2.1.2 Microfluidic Electrochemical Cell 
This cell operates as an alternative to the conventional cell and contains metal 
microelectrodes. It greatly improves the handling of the sample and the cleaning of 
the electrodes. It also allows on site real-time monitoring, hence provide much 
better pollution control [21]. Three major materials are used as electrodes in this 
type of cell; gold film or graphite-epoxy as (WE); silver-epoxy composite as 
pseudo-(RE); and graphite-epoxy composite as (CE). The potential of the reference 
electrode is stable and well defined in aqueous systems.  The potential of a pseudo 
reference electrode varies depending on the electrolyte. Pseudo-reference electrode 
is simple, and because this is immersed directly into the electrolyte used in the 
microelectrodes, the impedance effect is small. In pseudo-reference electrode there 
is no contamination of the test solution by electrolyte molecules or ions that a 
reference electrode might transfer. In contrast to conventional cell, the 
electrochemical response of microelectrodes may differ from that observed at 
conventional sized electrode in that nonlinear diffusion is the predominant mode of 
mass transport. The difference in mass transfer from the solution toward the 
electrode has many important implications that make microelectrodes very 
appealing in electroanalytical chemistry.  
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Moreover they possess a smaller time constant, and heightened signal-to-noise 
ratio. Cyclic voltammetry characterizes the performance of the microfluidic cell. 
The benefits of microfluidic cells include reduced solution consumption, less waste 
generation, online/in-line recognition; and minimal interference.  
 
LOC is a platform that combines many laboratory functions on one chip. 
Advantages of LOC: low fluid volume consumption, faster analysis and response 
times. LOC is also compact and small leading resulting in low fabrication costs. 
Fluid flow within microfluidic channels is laminar since it is normally characterised 
by law Reynolds numbers. Reynolds number is a ratio between inertial force (ρvs) 
and viscous force (μ/L). Laminar flow is particles of liquid that flow in a uniform 
way (straight lines). These liquid layers do not mix with neighboring layers due to 






Figure 1.4: Laminar Flow: the flow of a fluid when each particle of the fluid follows a smooth path, 















They have a range of analyte concentration in which the 
reaction of the sensor occurs linearly. 
 
Detection limit 
This is the lowest amount of a substance that the sensor 
signal can distinguish in the absence of a control sample. 
 
Sensitivity 
Their sensitivity enables them to respond to the required 
magnitude of the input signal that is required to produce an 
output with a specific signal-to-noise ratio. 
 
Selectivity 
The ratio of the signal output combined with the analyte 
alone compared with that of the interfering substance alone 
while keeping the analyte concentration constant. 
Reproducibility Their reproducibility determines the extent to which a 




The biosensors’ stability depends on sensor geometry and 
process of preparation. 
 
Response time 
Their response time is divided into two: steady state 
response time, which indicates the time required to reach 
95% of the biosensors’ response; and transient, which is the 
period required for the first output signal to reach its 
optimum after the addition of an analyte. 
 
1.1.2.2 Optical Biosensors 
Optical biosensor is based on the change of the optical properties of biological 
elements. Absorbance measurement is the simplest optical detection in biosensors, 
in which changes in analytes concentration that adsorb a certain wavelength of light 




1.1.2.3 Other Biosensors 
Other biosensors, such as the acoustic, thermometric, piezoelectric calorimetric, 
and magnetic biosensors work using distinct characteristics. Acoustic-based 
biosensors work based on surface or bulk-acoustic waves. Calorimetric transducers 
operate using changes in temperatures that result from the biochemical response at 
the sensing area. Biomimetic design has shown a promising future in the arena of 
nanomaterial technology. The biomimetic design combines three different 
technologies like genetic engineering, bioinformatics and biotechnology. These 
pose a large number of challenges to the field of biosensors. Different molecules 
have been designed specifically with special structural features by biomimetic 
processes that mimic similar behavior of enzymes and proteins.  Biosensor 
technology has advanced at a fast pace, with the synthesis of artificial molecules 
like biomimetic molecules, molecular imprinting polymers, aptamers and peptide 
nucleic acids. These artificial molecules are helping to address a number of issues, 
including the use of animals in the production of element and arduous labeling of 
elements with smart tags. The merging of biosensors with different technologies, 
such as information and communication technologies, three dimensional printing, 
solar cells and organic light emitting diodes [OLED] will represent significant 
progress in the role of biosensors in specific and selective environmental analysis. 
Biosensor technology still has to address a range of challenges in regard to the 
spatial and temporal distribution of the hazardous chemicals. Environmental issues 
can be handled proficiently with the aid of these interdisciplinary technologies, as 
nano sized micro detectors, which have rapid and multi detection sensors, are likely 




1.2 Molecular Recognition 
The success of biosensing is dependent upon molecular recognition. Molecular 
recognition refers to the ability of a molecule to detect another through bonding 
interactions and molecular geometry. Several forces and bonding processes are 
involved in molecular recognition and include hydrogen bonding, hydrophobic 
forces, and metal coordination. These and other forces are described below. In 
molecular recognition, the interaction between the host and the guest results in a 
detectable change. Molecular recognition is the basis of many processes in biology 
such as enzyme catalysis, receptor substrate binding, and the assembly of 
multiprotein complexes.  
1.2.1 Binding forces and Interaction involved in molecular recognition 
1.2.1.1 Electrostatic and Hydrophobic Interaction 
Electrostatic interaction occurs between charged molecules and surfaces with 
opposite charges and is exploited in molecular recognition. Hydrophobic 
interactions have a lipophilic property, which makes them a good substitute for the 
bio recognition of molecules.  
1.2.1.2 Covalent Bonding 
Covalent bonds giving high reversibility are usually incorporated into host 
molecules. The formation of a reversible covalent bond between two molecules 
follows a molecular recognition event. The strongest chemical bonds are formed by 
those covalent bonds having the highest energy forms.  
1.2.1.3 Hydrogen Bonding 
Hydrogen bonds provide directionality and specificity of interaction, which are 
important for molecular recognition. Hydrogen bonds occur between a protein and 
its ligands (protein, nucleic acid or substrate). Although H-bonds have less energy 
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(1 kcal/mol) than covalent bonds (100 kcal/mol), their multiplicity confers rigidity 
to protein/DNA structure, geometry, and specificity to intermolecular interactions.  
1.2.1.4 Specific Interaction 
Deterioration in functionality as a result of improved orientation and stability can 
be prevented by specific interaction-mediated immobilisation of molecules using 
DNA hybridisation or antibody-protein A/G interaction.  As protein A/G combines 
the domains of protein A and G, it has the additive property of forming both 
proteins, which are useful for biosensing applications. Protein A/G can be used as 
an immunological tool given that pathogenic bacteria such as Streptococcus and 
Staphylococcus have protein A and G on their surfaces, which bind IgG. Protein A 
binds to the Fc portion of IgG with affinity, which depends on the subclass of IgG 
and the species. The specificity of protein G for IgGs is broader than that of A, 
depending on the source and can bind to both the Fab and the Fc portions of the 
antibody molecule with affinities varying based on the species [22]. 
1.2.2 Types of Molecular Recognition  
1.2.2.1 Static molecular recognition 
This type of recognition resembles the interaction between lock and key. It exhibits 
a complex reaction in which the host and the guest molecule react in a ratio of 1:1 
to form a host-guest molecule. To obtain advanced static molecular recognition, it 
is important to make recognition sites that are specific for guest molecules [23]. 
1.2.2.2 Dynamic molecular recognition 
In dynamic molecular detection, the binding of the first guest to the first host-
binding site affects the subsequent binding of the second guest to the second 
binding site. In addition, in a positive allosteric system, the attachment of the first 
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guest increases the association constant of the second guest, while in a negative 
system the association constant is reduced. The dynamic nature of binding provides 
the method for controlling binding in biological systems [23].  
1.3 Antibody-Antigen Interactions 
Affinity refers to the strength of binding between an antigenic site and an antibody-
binding site. Affinity is the equilibrium constant that describes the antigen-antibody 
interactions. It is the sum of the attractive and repulsive forces operating between 
an antigenic site and an antibody-binding site. The reactions are noncovalent and 
irreversible since antibodies do not irreversibly alter the antigen that binds them. 
The interaction process involves hydrophobic, electrostatic, and van der Waals 
forces and hydrogen bonds. Van der Waals forces are the weak electric forces that 
contribute to intermolecular bonding between neutral molecules. The contribution 
of each interaction varies with the type of antigen or antibody involved. 
Immunoglobulin-antigen interactions typically occur between the paratope on the 
antibody at which the antigen binds and the epitope. When the epitope and the 
paratope bind, they become attracted as a result of long-range electrostatic forces, 
which overwhelm the hydration energies. After the expulsion of the water 
molecules, the molecules attract each other creating a distance that makes it 
possible for short-range forces, such as the van der Waals, to draw two 
complementary surfaces together. The strength of the binding depends on how the 
two interacting surfaces fit. If there are high salt concentrations, resulting extreme 
pH can disrupt the interaction between an antibody and its antigen.  
The process of measuring the binding strength between an antibody and an epitope 
is known as affinity. This interaction can be described by introducing the affinity 
constant Ka for the reaction   
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Ab + Ag = Ab-Ag.                            Equation   [1] 
Therefore, the amount of antigen-antibody complex formed at equilibrium can be 
expressed by the following formula. 
Ka = [Ab − Ag] /  [Ab][Ag]                   Equation   [2] 
Where-: 
I.       Ka is the affinity constant 
II.     [Ab-Ag] is the molar concentration of the antibody-antigen complex 
III.     [Ab] is the molar concentration of unoccupied antibodies and 
IV.    [Ag] is the molar concentration of the free antigen.  
Association and dissociation rate constants are defined as follows: 
Vass = kass [Antibody][Antigen] Vdiss = kdiss [Complex]         Equation   [3] 
where Vass and Vdiss represent the rates of association and dissociation, respectively, 
and kass and kdiss represent the rate constants of association and dissociation, 
respectively. 
At equilibrium Vass is equal to Vdiss and from eqns [1] and [3], the following 
equation is obtained: 
Ka = kass/kdiss                                               Equation   [4] 
Antibodies with high-affinity bind larger quantities of antigen with higher stability 
in a shorter compared to those with low affinity. The existence of additional 
binding sites on antibodies and antigens affects the stability of antigen-antibody 
complexes. The binding intensity between multivalent antibodies or multivalent 
antigens is termed as avidity. Avidity is influenced by factors that include the 
affinity of the antibody for the epitope, the number of antibody or antigen binding 
sites, and the resulting structure of the antibody-antigen complexes. [24-33].  
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The section below provides to offer a comprehensive and fundamental introduction 
to immunoassays and sets a context for subsequent chapters specific key elements 
of immunoassays. Immunoassay formats that range from non-competitive to 
competitive are available. These formats and their signaling systems, such as the 
colorimetric approach are examined. Lastly, the electrical signal transduction 
technique, which is used in the subsequent generation of immunoassays, is 
described.  
1.4 Immunoassays:  
Immunoassays are biochemical tests that use highly sensitive immunoglobulin (Ig) 
(antibodies) as binders to detect the existence of molecules present at low 
concentrations. Therefore, antibodies play an integral role in the immune system 
and are nature’s major detection tool. They are located on the surface of B-cells (B-
lymphocytes) and have the ability to detect the presence of any foreign antigens. 
The B-cells can recognise and signal the existence of a wide range of antigens that 
consists of molecules, such as prions, toxins, viruses, drugs, and aberrant 
biomolecules that attack our bodies. Immunoglobulin proteins exist in various 
formats. The five isotypes of antibodies are IgG, IgA, IgD, IgE, and IgM. Due to 
their high natural affinities and excellent half- lives, antibodies are the priority of 
targeted therapeutics and diagnostics. The half-life is the amount of time needed for 
an antibody to reduce to one-half its initial level value. The term is commonly used 
to describe how long stable antibody survives. Antibodies can be easily 
manipulated using standard molecular biological methods into customised 
antibodies that are structured to perform effectively in their chosen application. 
Investment in antibody-based diagnostics and therapeutics in the biopharmaceutical 
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industry has been heavy. Therapeutics is the largest and fastest growing class of 
biopharmaceuticals [34, 35].  
Antibodies occur in three forms:  
(i) Polyclonal antibodies- which are produced by mixing different B-cell clones. 
(ii) Monoclonal antibodies - which is secreted from a single clone of B-cells.  
(iii) Recombinant antibodies - which results from genetic manipulation of antibody 
genes [36, 37].  
 
This piece of research focused on the environmental application of immunoassays, 
and, in particular, on the quantification of polycyclic aromatic hydrocarbons 
(PAHs) in polluted water. Years of studies have greatly advanced the development 
of immunoassays that are now used to detect PAHs in soil and water samples. 
Some available immunoassays can be used to determine PAH concentration. 
Examples of this include chemiluminescence immunoassays (CLIA); 
fluoroimmunoassays (FIA); radioimmunoassays (RIA); and enzyme–linked 
immunosorbent assays (ELISA). These examples differ from each other in relation 
to their form of detection, be it UV, fluorimetric, amperometric or potentiometric 
[38].   
• Commercial immunoassays 
There is a relatively large number of commercially available immunoassay PAH 
detection Kits used in PAH. For example, BTEX RaPID Assay® is a rapid-field or 
laboratory enzyme immunoassay (from JJS technical services) that is able to 
analyse small aliphatic PAHs and carcinogenic PAHs (> 4 aromatic rings) [39]. 
Commercial immunoassays can sample-specific (e.g., designed for use with soil or 
water). Ensys PAH is a soil test kit that can be purchased from Strategic Diagnostic 
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Inc. The kit is used both as a qualitative and semi-quantitative assay, as it gives 
only an approximate value of the PAH concentrations present in soil [40].  Rapid 
Assay® PAH test kit (from Tigret Inc.) is used for qualitative, semi-quantitative, 
and quantitative analysis of PAHs in water (well water, surface water, and 
groundwater) [41]. Envirogard® (by JSS Modern Water) also detects PAH in 
water, and it includes the 16 PAH compounds listed under the Environmental 
Protection Agency (EPA) regulations. These kits are both rapid and reliable [42]. 
 
1.4.1 Types of Immunoassays:  













 Homogeneous assays do not require 
the separation of the bound reagents 
from unbound material. Fluorescence 
polarisation immunoassays (FPIA) 





 Heterogeneous assays, on the other 
hand, segregate the free analyte from 
the reagent-bound analyte. An 
enzyme-linked immunosorbent assay 




1.4.2 Enzyme-Linked Immunosorbent Assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) is a strategy used to distinguish the 
presence of an analyte in a sample. It is regularly the ' gold standard’ upon which 
different immunoassays are based. It is a quick, delicate, specific and reproducible 
strategy dependent on the ability of immunoglobulin to distinguish a particular 
antigen. ELISA can be utilized in numerous formats, with various read-outs. The 
chosen assay relies upon the recognition requirements, concentration of the analyte, 
the structure and size of the analyte and on whether the analyte is soluble or 
membrane-bound. ELISA is commonly used because of its high-throughput 
capacities, (it can measure numerous samples in a moderately brief timeframe). 
Immunoassay can be divided into ‘immunometric’ and ‘competitive’ assays (Fig. 
1.4). Immunometric are also referred to as sandwich assays. They require the use of 
two specific antibodies. The first immobilised antibody captures the target by 
attaching to one of its antigenic sites.  
 
The second detection antibody then attaches and produces a signal that is directly 
proportional to the concentration of the target in the sample. In the competitive 
assay, a free antigen and a labelled antigen compete in order to attach to the 
immobilised antibody. The higher the target level in the assay, the lower the 
amount of labelled antigen present for binding. Thus, the signal produced is 
inversely proportional to the concentration of the free target, as illustrated by the 
curve in Figure 1.5. A number of formats are commonly used such as capture and 










Figure 1.5: A typical response plot for each assay is illustrated and ELISA assays: capture and 
displacement assays. 
 
Immunometric assays are commonly used to detect molecules, such as viruses and 
proteins since they can facilitate the binding of more than one antibody. 
Competitive immunoassays must recognize small molecules (toxins). They use an 
analyte-specific recognition antibody and a ‘tracer’ molecule, a labelled version of 
the target analyte. The tracer is frequently labelled with a fluorophore or an enzyme 
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1.4.3 Signal Generation in Immunoassays:  
Identification methodologies can be characterized as ‘labelled’ and ‘label-free’ 
signaling methods. Labeled immunoassays utilize an antibody connected to a 
compound, fluorescent label, radiolabel, colorimetric or nanoparticle. In the case 
of labelled immunoassays, one of the reagents of immunoassay test is coupled 
with a label or something similar. It can be a fluorescent particle, a quantum dot, a 
dynamic redox atom or enzyme.  Labelled immunoassays, allow for identification 
of an analyte with a high sensitivity and low limits of detection [47]. 
Electrochemical strategies can be used in various configurations. Over the last 
number of years work has been carried out which has resulted in flow cell 
innovation being combined with electrochemical detection to make a range of 
labelled immunoassays. Some of the previous works are outlined here [47]. The 
combination of electrochemical recognition with advanced ELISA innovation has 
permitted the improvement of high throughput techniques, which allow the 
completion of numerous assays in short periods. The first historically speaking 
immune response detection methods applied the utilisation of radiolabels [48]. 
Rosalyn Yalow and Solomon Aaron Berson announced the primary use of 
radiolabels in an immunoassay to identify insulin during the 1950s [48, 49].  
 
Hazardous working situations, problems with waste elimination and potential 
medical problems related to dealing with radioactivity resulted in a rapid 
advancement in alternative detection methods. Current methods are more secure 
since they do not present health risks to the operator and waste produced can be 




Nowadays, radiolabels have been generously replaced with recognition techniques 
that provide high sensitivities, while utilising much safer methodologies. 
Colourimetry is a system that is utilized to measure coloured substances in a 
sample.  
Upon enzymatic activity, chromogenic substrates produce coloured compounds. 
The catalyst, soluble phosphatase (AP), is an alternative indicator, which 
generates the enzymatic label (Figure 1.6). It has an estimated molecular weight 
of 86 kDa. Because of its large size, antibodies with AP must be produced 
carefully, to guarantee that the conjugation level does not hamper access for target 
binding.  AP is more costly than peroxidase. A drawback associated with having 
AP is that it is active in alkaline conditions and inactive in inorganic buffers or in 
chelating agents. However, acidic conditions (pH < 4.5) attributes may be 
beneficially utilized as reaction stopping agents. The AP substrates are non-toxic 
and moderately steady. For instance, p-nitrophenyl phosphate (pNPP) remains 























Figure 1.6: (a) Upon the reaction of the pAPP with AP, 2 electrons were generated with p- 
aminophenol. (b) Hydrolysis Enzymatic reaction of pNPP to chromogenic p-nitrophenol catalyzed 
with alkaline phosphatase AP  
 
1.4.4 Electrochemical immunoassay applications 
Transduction techniques simplify detection mechanisms, reduce assay times, and 
decrease the number of assay steps and assist in facilitating the multiplexing of 
immunoassays. Electrochemical transducers are a fundamental part of 
immunoassay motioning, so, electrochemistry identifies with the production of an 
electric current amid a chemical response. The most widely recognized kind of 
electrochemical reaction utilised in biotechnology is the oxidation response or 
redox reaction, during which electrons are exchanged between two connecting 
species. Electrochemical systems are frequently utilised for use in coloured and 
thick media [53, 54]. Electrochemical immunoassay transducers can accomplish 
high sensitivities. Electrochemical immunosensors, for the most part, have low 















recognition platforms [54]. The application of electrochemical biosensors was first 
recorded in the 1960s. These early biosensors used enzymes, such as in the initial 
paper by Leyland Clark, where glucose oxidase was utilized as a catalyst to 
facilitate the reaction between glucose and oxygen. Its consumption could be 
measured by oxygen electrodes [55]. The management of diabetes is usually done 
by electrochemical biosensors, which can measure the level of blood glucose [56].  
Electrochemical biosensors are generally quick to detect analytes and are 
uncomplicated. They can also be easily carried and are less sensitive to 
interferences than optical ELISA. These advantages make them more favourable 
than other immunoassays. In addition, the commercialisation of economical screen-
printed methods and the production of desirable ink formulations necessitate the 
mass production of electrochemical sensors, which potentially reduces production 
costs.  
 
Early enzymatic biosensors was based on the production or consumption of 
electroactive substrates, such as hydrogen peroxide or oxygen, while the second-
generation biosensors was based on electroactive substances, such as ferrocene 
compounds [56, 57]. Third generation biosensors involved directing an enzyme to a 
substrate [56,58]. However, all of these stages need electrochemical oxidation or 
reduction reaction to occur.  One major issue arises as a result of the interactions of 
antibody-antigen interactions, which are based on hydrogen bonding and other non-
covalent interactions meaning that the detection of reactions using electrochemical 




However, labelling of different elements of the immunoassay or using ‘label-free’ 
electrochemical techniques such as AC impedance can effectively address this 
challenge. An antibody component is bound onto a surface. When put in a solution 
with its antigen, a recognition reaction takes place where the antigen is attached. 
Detection of this binding, however, requires a transduction reaction where this 
binding is transformed into a signal. An early illustration of an electrochemical 
immunosensor was published in 1991 [59].  The reader is referred to [60] for an 
account of research in this field up until 1997, while more recent information can 
be found in other reviews [61–63]. Electrochemical immunoassays and 
immunosensors are not costly compared to techniques such as surface plasmon 
resonance (SPR), rapid, and quantitative (unlike lateral-flow assays). Additionally, 
coloured or turbid solutions do not interfere with them. The base electrodes 
essential for these tests can be mass-produced using standard screen-printing 
technology.  
 
Additionally, only small quantities of highly costly biological reagents are required, 
which minimises the cost of production. These benefits make electrochemical 
methods highly effective for high output mass- screening programmes. Screen-
printing micro fabrication technology is an emerging field, where sensor devices 
have been fabricated on the screen-printed electrodes (SPE) [64]. The main 
advantages of these electrodes are that they are cheap, planar, miniature, disposable 
and thick film electrodes. These electrodes are mainly of pocket size and are easy 
for on site monitoring. [65] There are different configurations of SPE in the market 
that have wide applicability as per the requirement of the customer.  
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The configuration of the working and reference electrodes is called the first 
generation SPE while the configuration of the working electrode, reference 
electrode and auxiliary electrode is called the second generation SPE [66]. Recently 
there are also multiplex working electrodes like eight SPE and 96 SPE that have 
been used for detection of multiple biomarkers simultaneously. [67] Recent SPEs 
have been designed, which replace solid substrates with paper substrates for 
development of novel electroanalytical tools for the detection of a broad spectrum 
of biomolecules. [68]. In the medical field, there are SPE biosensors that take the 
form of technologies that can be worn or tattoos imprinted on skin for sensing 
medical conditions like heart rate, skin temperature, activity of brain, hemoglobin 
in blood and blood pressure. [69].  
 
1.4.5 Immunoassay Optimisation: In order to measure biological compound 
with remarkable accuracy, sensitivity and specificity, the optimisation of various 
aspects of the assay must be ensured. It is essential at this phase to prepare enough 
immunoassay reagents that are destined to be adequate for the entire test.  All 
analyte regents and antibody agent (ideally very refined to decrease any form of test 
interference) should be fully characterised from the outset. Creating and purifying 
more analyte or antibody during a test will require re-optimisation of the 
concentration of reagents and conditions that could influence the reproducibility of 
the experiment. These reagents ought to be stored with the goal that recurrent use 
does not affect the respectability of the sample (for example store in vials at −20◦C 
ideally at −80◦C). Ligand binding assays (LBA) are techniques that rely upon a 
specific method of attaching an analyte to an antibody. Commonly these are 
reversible binding occasions governed by the laws of mass action [70].  
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Law of mass action states that unbound reactants is in equilibrium with bound 
reactants. It shows that the rate of forward reaction equals the rate of backward 
reaction. In LBA format the specific binding of an antigen to an antibody involves 
reversible non-covalent interactions governed by the laws of mass action. The laws 
of mass action relates to the assay’s sensitivity in that the sensitivity of the assay is 
proportional to value of Ka (the amount of the antigen-antibody complexes). 
Reasonable test optimisation ought to be embraced to guarantee that the assay is 
carrying out to its maximum capabilities. For instance, minimum dilution, coating, 
detection, washing concentration solutions and incubation period ought to be 
assessed experimentally.  
1.4.6  Immunoassay Buffers: The antibody/antigen reaction is made to work 
effectively under physiological situations. Therefore, physiological pH and ionic 
strength should be utilized. Widely used buffers in immunoassays are described in 
(Table 1.4).  
 
 Table 1.4 Buffers used for immunoassay formats. 
 
Application Buffer pH 
 
Coating 
50 mM carbonate/bicarbonate: 0.05g NaCl, and 2.1g 
sodium hydrogen carbonate, bring to 500 ml with 




3.0285 g Tris in 500 mL diH2O Discard 250 µl of the 
mixed solution and add a 250 µl Tween 20.  
7.4 
Blocking 3.0285 g Tris in 500 mL diH2O.  7.4 
Substrate 4.793 ml of diethanolamine reagent (DEA) into 500 mL 9.5 
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1.4.7 Immunoassay Validation:  
In its most conventional structure, an immunoassay is a bioanalytical technique 
involving the specific binding of an immune protein agent (antibody) with its 
analyte. Detection is accomplished by the addition of a reporter label that generates 
a reaction to the analyte [71]. The goal of assay validation is to have the capacity to 
characterize an assay as far as statistically measurable parameters are concerned 
with estimated certainty.  
 
The designation of validated analysis is possibly merited when it has been 
described as far as its ability to classify tests regarding the presence or absence of a 
specific target [72].  Analytical strategy validation combines all the procedures that 
show that a particular technique used for the quantitative test of analytes in an 
obtained sample, e.g., blood, plasma, serum, urine, sweat or milk, is dependable 
and reproducible for the expected use [73]. The basic parameters for validation are 
include yet are not constrained by (1) accuracy, (2) precision, (3) selectivity, (4) 
reproducibility, and (5) stability. Validation procedures include documenting using 
specific research investigations; and ensuring that the experimental characteristics 
of the technique are appropriate and reliable for the intended, analytical purposes. 
The acceptability of analytical information corresponds straightforwardly to the 
criteria used to validate the method.  
 
Limit of blank (LOB), limit of detection (LOD), and limit of quantitation (LOQ) 
terms are used to determine the smallest concentration of an analyte that can be 
reliably detected by an analytical method. International Conference on 
Harmonization [ICH] Q2 suggests these methods for measuring limits.  
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These methods of limit determination uses the mean and standard deviation of 
blank samples to set the limits (see Equation 1 and Figure 1.7): 
LOB = Mean blank + 1.645 * Stdev blank (one sided 95%) 
LOD = Mean blank + 3.3 * Stdev blank (one sided 95% * 2) 
LOQ = Mean blank + 10 * Stdev blank (one sided 95% * 6) 
[Eq. 1].  
 
 
Figure 1.7: Limit of blank (LOB), limit of detection (LOD), and limit of quantitation (LOQ) based 
on the blank. 
 
• Define Calibration Model: 
The choice and arrangements of standard plots are central in the design, validation 
and utilisation of all quantitative assay strategies. Calibrations curves arranged from 
heterogeneous, contaminant, and/or poorly characterised analytes are more likely to 
generate uncertainty and greater variability [74]. The calibration plot model picked 
should be the model that yields the best fit to our data. A substandard curve fitting 
will produce test percentage error and enlarge the amount of substance at which the 
limit of quantification (LOQ) can be characterized. LBA detects the signal of a 
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progression of interactions that follow the law of mass action, bringing about a 
nonlinear and frequently sigmoidal calibration curve. Four-parameter logistic 
regression is regularly utilised to fit the LBA calibration curve [75]. It is advised 
the calibration model be set up at least three times with no less than eight different 
concentrations in duplicate. The utilisation of the correlation coefficient is not 
suggested for affirmation of the regression model [76]. For a model to be useful, it 
is recommended that the mean %RE of calibrators within the intended validity 
range be commonly close to 10% [77]. Sometimes, if contrasts in bias and precision 
are insignificant, it might be desirable to choose a straightforward model rather than 
a precise but complex one. The least complicated model that sufficiently illustrates 
the concentration reaction should be utilized [78].   
• The limit of detection [LOD]:  
This is the most minimal concentration of target in an assay that can be recognized 
yet not quantified [79]. The limit of detection is frequently mistaken for the 
sensitivity of the test strategy. The sensitivity of an analytical approach is 
dependent upon the capacity of the technique to separate small contrasts in 
concentration or mass of the assay target. In experimental terms, sensitivity is 
represented by the incline of the calibration plot that is given by plotting the 
analytical response against the target concentration [79]. LOD is a fixed parameter  
used to describe an analytical confirmatory strategy.  It may be characterised as the 
most minimal analyte concentration likely to be dependably recognised from the 
limit of the blank (LOB) and at which recognition is feasible. In this way, it is 





1.5 Immobilisation strategies for biomolecules onto solid surfaces  
Picking the most reasonable immobilisation technique is fundamental in the 
advancement of any test, as it must enable the ligand to hold its action and 
furthermore guarantee that the fitting binding sites are presented to the coupling 
antibody [80]. Immobilisation of an antibody to any surface can be accomplished 
through physical, covalent or affinity techniques. Physical adsorption interferes 
with ionic, hydrophobic and polar between inter-molecular reactions (reacting 
groups in different molecules) that can happen between an antibody and chosen 
surfaces [81]. Physical adsorption is a less costly and simple antibody binding 
strategy. It can, however, result in the random orientation of the antibody onto the 
solid phase, and may lead to the diminished presentation of critical sites. It should 
be noted that physically absorbed proteins can be removed effectively by washing 
with a detergent. Covalent immobilization can be done by connecting directly with 
reactive groups (for example NH2 –COOH or –SH) or by chemically function- 
alising the proteins to empower linkage [80] Pierce Thermo Scientific offers a 
range of immobilization technique kits [82]. Before beginning the immobilization 
procedure for an antibody, the following factors ought to be studied or optimized:   
•    Choose either a direct or capture attachment methodology;  
•    Indicate the purity and concentration of the antibody; 
•   Search for the ideal solution pH for the immobilization response; 
•   Identify residues in the antibody agreeable for attachment, for example, cysteine; 
•    Control the perfect incubation time; 
•    Select the ideal ionic quality response solution; 
•    Find the most suitable coupling procedure based on the groups accessible and 
the requirement for a linker (or not) 
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o    Amine  
o Carboxyl  
o Thiol  
o Aldehyde  
o Pegylation  
o Maleimid 
The immunoassay has developed extremely since its introduction in 1959 [83]. 
These have been driven by an increase quest for sensitive, specific and quick 
detection methods while reducing expenses and eliminating the need for highly 
experienced personnel. Developments in immunoassay efficiency have taken place 
in two areas the enhancement of the recognition antibody and improvement of the 
recognition platform.  
1.5.1 Enhancement of the recognition antibody  
The main properties of antibodies, particularly their greater affinity and specificity 
for an analyte, make them favourable in numerous applications in biotechnology, 
diagnostic, and biomedical areas.  The introduction of hybridoma technology in 
1975 and the subsequent ability to create monoclonal antibodies (mAbs) have 
resulted in an increase in antibody study and advancement. Consequently, the area 
of monoclonal antibodies has grown into a thriving industry and has a substantial 
impact on rich sources of diagnostic, therapeutic, and research reagents. The 
universal increase in demand for immunoassay testing was around $15.6 billion and 
$16.3 billion in 2011 and 2012 respectively. This market was expected to surge to 
an estimated $20.5 billion by 2017 [84] with the research in antibodies reaching 
nearly $2 billion and $2.2 billion in 2013 and 2014 respectively. The market is 
expected to reach approximately $3 billion in 2019 [85].  
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The initial challenges resulting from immunogenicity of murine mAbs have been 
minimised or eliminated, by the advancement of mechanisms to generate chimeric, 
humanised and fully human antibodies [86]. The global demand for antibody drugs 
was estimated to be worth $63.4 billion in 2013. This market is anticipated to 
expand to nearly $122.6 billion globally in 2019, based on the BCC Research [87].  
1.5.2 Improvement in platform and recognition performance 
New antibody molecules with higher affinity and specificity properties could 
profoundly affect the next generation of immunoassay research. However, 
recognition antibodies comprise of only one of the numerous elements that require 
further research to reduce the level of analytical detection. Advancements in 
antibodies, platforms, signal production and acquisition have all played a 
significant role in the recent generation immunoassay growth. The combination of 
nanosised materials into different assays is the primary focus of the whole field of 
biosensors research. Nanosized materials involve a broad range of organic or 
inorganic components where one dimension is at least < 100 nm. Nano, a Greek 
prefix, refers to the smallest natural parts while the term nanotechnology describes 
the manipulation of the materials that show powerful electrical, mechanical, 
chemical or optical features [88]. These components have been evaluated and 
optimised to provide essential tunability, intensities and longevities that are larger 
than common labels or dyes [89].  Nanoparticles possess various chemical and 
physical characteristics that enable them to produce the outcomes that allow them 
to be used as probes in analysis [90]. A broad range of nanomaterials, such as 
enzyme- loaded carbon nanotubes, nanoparticles, and semiconductor nanoparticles, 
have been utilised to improve the signal produced by the antigen-antibody 
interaction [91].  
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Nanomaterials have been used extensively as immunosensors. A potentiometric 
immunosensor with nanoparticles has been magnetically functionalised with an 
antibody to human (IgG). The immunosensor was a carbon paste electrode that 
used for the detection of the analyte of interest. For the antibody coupling to the 
nanoparticles a covalent immobilisation method was used and the linear response 
range was from 0.1 to 1.2 ng mL-1 [92].  Another study revealed the application of 
magnetite nanorods for carcino embryonic antigen within a range of 1.5-80 ng mL-1 
with a detection limit of 0.9 ng mL-1 [93]. The nanoparticles of the complex 
CoFe2O4 were used for the fabrication of immunosensors that were used for the 
detection of a-Ferroprotein. Analysis yielded similar result with the ELISA results 
from human serum samples. [94] 
• Magnetic beads:  
The synthesis of magnetic beads can be carried out by three general methods. In the 
first method the magnetic particles are synthesised inside polymer matrix. In the 
second method polymer is synthesized in the presence of magnetic particles. In the 
third method the beads are prepared from pre-formed polymer and magnetic 
particles. Electrochemical immunosensors use magnetic (MBs) beads for the 
separation and transport of antibodies [95]. Their high surface area, low toxicity, 
chemical and physical stabilities, and biocompatibility make them effective [96]. 
The process allows antibodies to react with the magnetic beads before adding onto 
the electrode surface using an external attraction. DropSens currently offers a 
custom made external attraction to be used alongside with their SPEs. This method 
does not involve the electrode in the immunological process since it can lead to 




Magnetic particles (MPs) have been determined to be a stable solid phase in 
immunoassays and electrochemical Immunosensors [98,99]. In the case of 
Electrochemical Immunosensors (EI), the immunoassay reagents are generally 
added on the working area of the electrochemical cell (transducer). In magneto-
electrochemical immunoassay (EMIs), MBs are utilised as a solid surface and the 
immunoreaction takes place in the outer electrochemical cell. The entire test, 
typically, takes place in a test vial. In every incubation and wash step, immunoassay 
reagents are blended in a shaker and collected on the wall of the glassy vial by 
utilising a commercially accessible attractive separator. After the immunoreactions, 
the MBs coupled with the immunoassay reagents are moved to an electrochemical 
setup and identification follows. MBs can be attractively collected onto the working 
area of the electrochemical cell [100], and the measurement is conducted. A 
correlation between the two strategies, EI and EMI, has been accounted for by 
Centi et al. [101].  
 
Electrochemical identification was carried out on (SPEs). Although the two 
techniques were improved for electrochemical immunosensing, EMI made it 
possible to achieve quicker and progressively more sensitive immunochemical 
detection. Other announced methods for magneto-electrochemical immunosensing 
(EMI) have focused for instance on MBs as reasonable carriers of covalently 
attached enzymes for planar biosensors [102]. MBs are chemically and physically 
steady materials. They are biocompatible, and they can be effectively and 





The outside of MBs can be synthetically modified, which permits the connection of 
biomolecules, such as DNA, chemicals or antibodies. These favourable 
circumstances permit a large number of immunoassay designs [103-104]. 
Additionally, the use of modified MBs in immunoassays as a solid phase for 
immunoassay reagents can develop the efficiency of the immunological response 
because of the expanded surface (high stacking of immunoassay reagents 
permitted). Immunoreactions can benefit from quicker assay motion since MBs can 
be scattered effectively into the solution with just a delicate shake. The analyte does 
not have to migrate far in the MBs colloidal suspension. EMI can be scaled down, 
and the entire immunoassay can be automated. Possible sampling and magnetic 
separation methods for scaled down and automated EMI methods have been 
identified [105]. An integrated microfluidic approach based on magnetic beads as 
both attachment phase and molecule carriers have been created for quick and low-
volume immunoassays utilising MB [106]. The absolute time required for the 
already developed approach based on magnetic beads was less than 20 min with the 
incubation times included, and the test volume used was under 50 µl for 5 repetitive 
assays. The key components in the presented approach were a detector and a 
magnetic separator.  
 
1.6 Lab-on-a-Chip Immunoassay Systems 
Lab-on-a-Chip shows a main technology to enhance sensor performances in terms 
of being able to decrease the use of reagents and the waste volumes, automation. 
Miniature and portable sensors help to overcome the difficulties associated with 
multi residue analysis and real time in field measurements. In addition, eco-
designed portable devices have been constructed which have advantages, such as 
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relatively low cost and high automation during environmental analysis. This 
research focuses on lab on chip platform that is effective for analysis of PAH 
environmental pollutants. Immunoassays are the best quality level system for 
recognising a panel of biologically critical antigens. Besides, latest trends are 
characterised by the combination of biomedical designing and immunoassay 
improvements, leading to the generation of miniaturised microfluidic systems with 
the capacity to recognise relevant analytes in a quick, sensitive and dependable 
way. The current 'lab-on-a-chip' immunoassay is characterised by four key 
components (I) accessible surfaces, (ii) microfluidic platform design and 
manufacture, (iii) systems for the transporting and mixing of immunoassay 
compounds and (iv) the combination of antibodies as recognition components. A 
detailed explanation of ‘lab-on-a-chip’ immunoassay platforms to illustrate the 
huge potential for sensitive recognition and the nature of assessment for multiple 
elements exceeds the scope of this discussion.   
 
With the evolution and enhancement of other immunoanalysis platforms particular 
emphasis has been placed on the advancement of miniaturised configurations where 
the test is completed using networks of enclosed channels whose configurations 
match in the micron scale. In such tests, immunoassay samples (e.g. buffer 
containing the target of interest) show laminar flow characteristics where fluidic 
streams flow parallel to each other, with mixing taking place by diffusion [107]. 
These fluidic platforms have numerous benefits over standard immunoassays. 
Firstly, the reduced dimensions of integrated techniques lead to a significant 
decrease in the number of reagents that are required for immunoanalysis.  
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This integration can be a significant consideration where costly chemical reagents 
are needed. Secondly, the increased surface-to-volume ratio exhibited by these 
miniaturized components facilitates quicker antibody/antigen interactions and 
consequently leads to quicker assessment. Thirdly, most lab-on-a-chip platforms 
can be transformed to incorporate automation systems, which can influence the 
development of the assay reproducibility. 
1.6.1 Substrates Used for Microfluidic Chip Design: the fabricating and 
production of the fluidic system is determined by the selected substrates. These 
combine silicon, glass and polymers [108– 110]. When choosing a substance for 
utilization in a 'lab-on-a-chip' immunoassay, it is important to choose a substrate 
that enables the planned assay to be produced logically and cost-effectively, 
without any detrimental impact on any of the assay compounds by not exhibiting 
any toxicity-related properties should be chosen. In addition, the component chosen 
must be much perfectly with the identification methodology to be connected. For 
instance, in the case of an immunoassay where fluorescently labelled detection 
antibodies are to be integrated, it is fundamental that the material does not have any 
natural fluorescent properties that might interfere with the investigation. Also, the 
material ought to effortlessly permit fluidic channels to be integrated for the benefit 
of sample delivery and mixing (if pertinent), and should also be preferably fit 
towards the mass-transfer of analytical parts [111, 112].  
1.6.2 Microfluidic Channel Design and Fabrication: A computer-aided design 
(CAD) approach is commonly chosen to structure the microstructures of a 
microfluidic platform. Several economically accessible platforms (for example 
AutoCAD, DraftSight, SolidWorks and Creo), which give a schematic description 
of the last microfluidic channel can be selected. When designing the structure, it is 
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necessary to consider the following: (I) the relative size of the analytical system, (ii) 
the number of paths required for use and (iii) the channel measurements, with 
attention being paid to length, width and stature. In most instances, no less than one 
valve (for test addition) and channel should be provided for each reagent.  Channels 
should be short and conceivable to limit the transfer distance. However they must 
be of adequate length to prevent cross-contamination between various reagents 
caused by minor fluctuations in flow driving force [113]. Finally, when planning 
such models, it is necessary to integrate a waste-accumulation channel for 
encouraging the simple expulsion of waste regents, e.g., unwanted antibody and 
wash buffers.  
1.6.3 Analyte Delivery, Mixing and Washing: When conventional 
heterogeneous immunoassays are produced in microtitre plates with at least 96 test 
wells, they usually require approximately six successive steps to be specific to an 
analyte (I) preparation of the test samples (ii) introduction of bioreagents (for 
example antigens, antibodies) by means of pipetting, (iii) incubation time, (iv) wash 
solution (v) substrate production and (vi) recognition (for instance colourimetric). 
These procedures are comparative for microfluidic uses, and the implementation of 
innovative methodologies for analyte transfer and subsequent washing is to develop 
immunoassay sensitivity and performance [114, 115]. The pressure-driven flow can 
obtain the delivery of immunoreactants solutions through the microfluidic channels 
[116].  
1.6.4 Antibody Integration: Microfluidic immunoassay configurations can be 
both heterogeneous and homogeneous. Homogeneous immunoassays include 
interactions among antibodies and antigens in a buffer, and for microfluidics-based 
immunoassays bound and unbound antibodies are normally discriminated by their 
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electrophoretic mobility properties in microchannels [114]. Interestingly, 
heterogeneous measurements routinely use antibodies, which are directly attached 
on the solid phase of the microdevice or on the other hand, are cross-linked to 
micrometre sized particles that are combined inside a system (Fig. 1.8). The 
viability of the antibody immobilisation method profoundly affects test 














Figure. 1.8: Schematic representation of homogeneous (bead-based) and heterogeneous 
immunoassay formats available for ‘lab-on-a-chip’ applications.  
 
1.7 Trends in instrumentation and technology 
Analysis of water in the required environment by electroanalytical instrumentation 
has developed to a great extent.  Factors including sensitivity, specificity, and 
minimum time for sample preparation, cost and portability have been greatly 
42 
 
improved in modern equipment. These modern devices, such as remote sensors, 
mini lab on a chip instruments and electrode technologies are utilized for the in situ 
analysis of pollutants in large water bodies, such as rivers. Hanrahan et al., [117] 
have outlined the major issues that have to be addressed for the development of in 
situ electrochemical devices. They reported that modification of certain factors, 
such as stability for long term use, changes in natural conditions, (such as oxygen 
or convection) specificity and reversible electrochemical processes have to be taken 
into account in order to improve the response of the sensors. These factors affect 
the calibration for in situ analysis, thereby reducing inaccuracies when taking 
measurements [118]. Different factors including pH, ionic strength and temperature 
changes are related to depth in sediments and water. The surface layers of fresh 
water and sea water, the interface of water and sediment, and estuaries may exhibit 
very strong gradients of ionic strength and pH. They may affect not only the metal 
speciation but also the rate of electron transport at the electrode which in turn will 
influence the signals obtained during analysis. Electroanalytical techniques are 
appropriate for integration in lab on a chip system, thanks to miniaturisation of 
detectors and electronics.  
 
Polymer micro machining systems and micro electromechanical systems (MEMS) 
are used for construction of electro chemical sensing based portable analysing 
systems and lab chips for different environmental analysis [119]. These miniature 
devices are placed on the contaminated sites, which aid in the analysis of sample in 
a relatively quick timeframe. Namour et al [120] discussed various microsensors 
equipped with amperometric, conductometric and voltammetric technologies for 
the analysis of major pollutants targeted in the EU water framework directive. The 
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major drawback limiting sensors applications in ambient water is that the lack of 
ruggedness (the ability of an analytical system to remain unaffected by variations in 
method parameters) of receptor in different conditions of the environment. Screen 
printing technology is the most outstanding progress with respect to electrodes 
design and fabrication for environmental water monitoring. The base for multiple 
developments in environmental analysis for the screen printed electrodes is mainly 
bismuth, carbon and gold working areas. Application to water sample, mainly 
focused on trace element detection have obtained promising methods for in field 
sensing of toxic pollutants in water. Li et al [120] have reported on a wide variety 
of uses of screen printed electrodes have been used in different environmental 
analysis. Another promising method in this arena is the introduction of imprinted 
polymer molecules in working electrode designs which exhibited superior 
performance in the detection of pollutants in water [121].  
 
There has been a constant demand of chemical information about water bodies, as 
consequence of intensive water research, stricter guidelines for environment 
protection and growing public concern. Monitoring points for the pollutants depend 
on the density and location. In situ and on-site monitoring, the concept of 
geoesensor networks has been used for the miniaturisation and simplification of the 
devices. There is now demand for the development of wireless analytical devices 
which would reduce the analysis time for detection of water pollutants. The most 
significant factors are the management of data from a range of sources and the 
control of errors in analysis. Thus, the concept of screening and monitoring 
emerging tools (SMET) has emerged in order to address these issues.  
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Electrochemical sensors are the most common method used to overcome the 
limitations resulting from the aforementioned challenges, so they will play a 
significant role in the detection of ambient water bodies.  The organic light emitting 
diode (OLED) has been become an emerging technology in different spheres of 
research, during the last decade, whereby diodes are the source of excitation. It has 
an organic semiconductor layer that is placed between two electrodes that emits 
light in the presence of an electric field. Digital displays and portable systems are 
also made using OLED. OLED devices are also designed as sensing equipment 
[122], which have been widely used for environmental analysis [123].  
 
Tsopela et al. [124] reported the construction of a lab on chip designed integrated 
OLED which was acted as an electrochemical micro sensor for the analysis of the 
toxicity of water. Significant improvements in sensitivity can be achieved using 
microarrays and nanoarrays techniques. A comparative study between the 
microelectrodes and planar electrodes indicated that the diffusion profile of 
microelectrodes is hemispherical while that of planar electrodes are linear (Figure 
1.9). The hemispherical diffusion pattern of the microelectrodes increases the 
sensitivity as well as responses that do not depend on the flow of the analyte. 
However the signals produced by the microelectrodes are smaller than that of the 
larger electrodes. Thus, an array of microelectrodes is required to generate a strong 

















Figure 1.9: Diagram showing characteristic diffusion profiles of (a) a macroelectrode and (b) a 
microelectrode. The arrows indicate the direction of analyte diffusion to the surface of the electrode. 
In the case of the microelectrode the diffusion is a faster mass transport and therefore to a higher 
response.  
 
Precaution should be taken when constructing an array of electrodes to ensure that 
they are properly spaced, to avoid the overlap of the diffusion profiles and to be 
sure that the qualities of the individual microelectrodes are displayed. Reports 
reveal various design of microarrays based on different techniques. Nanoarrays 
have also been reported using carbon nanotubes. A recent report discussed the 
design of immunosensors using a label free electrochemical immunosensors 
technique. The report described fabricated gold microelectrode arrays with a finger 
thickness of 5 μm being designed by photolithographic methods. Thiols were 
absorbed on the microelectrode arrays to which cortisol specific monoclonal 




Five by five arrays of gold microelectrodes were designed by photolithographic 
methods having a dimension of 25 × 25 μm which were deposited with di-
isocyanate cross-linked antibodies. The recognition of aflatoxin M1 in milk was 
reported by a HRP labeled immunoassay having a detection limit of 8 pgmL-1 and a 
dynamic range of detection within 10–100 pg mL−1 [126]. 
 
1.8 Water pollution 
Diseases arising from water borne toxic chemicals pose a constant threat for both 
developing as well as developed countries. Rainwater is a medium for transporting 
the pollutants from the atmosphere to the earth’s surface. Anthropogenic and 
natural substances transfer to water bodies and ground water. According to the 
European Environmental Agency [127], approximately 25% of the groundwater in 
Europe is polluted.  Human activities in various arenas have led to an increase in 
pollutants e.g., nitrates in groundwater. Another source of pollution of the 
groundwater is the disposal of untreated wastewater and solid wastes to the water 
bodies. The sources of the chemicals present in water are either natural or from 
different human activities. Natural sources of chemical pollutants include climate, 
soil erosion and leaching and weathering of rocks. Human sources of chemicals are 
related to complex industrial activities, such as oil drilling and mining. Other 
human sources are sewage wastes, fuel leakages and solid wastes. Certain 
agricultural activities produce different chemicals, such as fertilizers and pesticides, 
which find their way into the ground water from the fields. Additionally the 
construction sites also generate large chemicals that are released into the ground. 
The main categories of water pollutants are shown in Figure 1.10.   
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    Figure 1.10: Environmental water monitoring parameters.  
 
 
1.9 Polycyclic aromatic hydrocarbons (PAHs)  
PAHs are a type of contaminant present in environmental pollutants. The structure 
of PAHs comprises of two or more fused aromatic rings. The molecules in the 
vapour phase (a molecule that is a mixture of two phases at room temperature) 
contain PAHs having between two and four fused aromatic rings. PAHs have been 
identified as one of the major risks associated with food consumption and 
environmental safety. Historically, much public attention has been given to PAHs 
due to their toxic and carcinogenic effects. Molecules of PAHs having more than 
four fused rings are present as particles in the atmosphere. PAHs can be found in 
aqueous phases, such as ground water, surface water and drinking water. However 
the concentration of these compounds is very low in ground water. The 
concentration of the contaminant in surface water is very high due to 
contaminations from oil products carried by wastewater during disposal. Drinking 
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water becomes contaminated as result of the water pipes used to supply water. 
Contaminant molecules diffuse from the coal tar that is used as a coating for the 
water pipes to the water flowing through the pipes. PAHs are both generated by 
natural processes as well as anthropogenic processes. Natural sources of the 
contaminant are volcanic eruptions and forest fire. Other sources relate to the 
incomplete combustion of wood, gasoline and coal. Additionally this contaminant 
enters the environment from the emissions of cooking gas and fuel used in vehicles. 
Emissions from tobacco smoking also contribute a minor amount of PAHs to the 
environment. Only small quantities of PAHs are made for commercial purpose. The 
contaminants present in air, water and soil matrixes usually have PAHs as their 
major constituent [128-137].  However the concentration of the pollutant differs 
based on its locality, sources and the matrix. Its concentration is lower in water than 
in air and soil as it is a hydrophobic molecule and has poor affinity towards water. 
Industrial pollutants and oil leakages are two factors attributed to the contamination 
of soil by PAHs [138,139].  
 
1.9.1 Health issues pertaining to PAHs  
PAH molecules can enter the human body [140] via number of routes: contact, 
ingestion and inhalation [134-136]. The health impacts of PAHs depend upon the 
type of contact route, PAHs concentration and contact time [137]. The 
consequences of exposure to these pollutants are shown in Table 1.5.    






Table 1.5: The effects of PAHs in short and long contacts. 
 
The lipophilic character of these molecules aids in their accumulation in the human 
body. Some PAHs form carcinogenic species that bind to the DNA in humans and 
animals through metabolism. Metabolic processes involving PAHs lead to the 
production of toxic metabolites that can attach to DNA, resulting in gene mutation. 
Some occupational exposure may cause lung and skin cancers [147]. The 
Environmental Protection Agency has identified 16 PAHs as major pollutants 
(Figure 1.11). The Scientific Committee on Food of the European Commission 
analysed 33 potent PAHs of which 15 were found to be both genotoxic and 
carcinogenic [148]. In the European Union (European Union under the Drinking 
Water Directive [149] the limit of concentration values of PAHs permitted in water 
is set at 0.1 µg/L. Among all the toxic PAHs, benzo[a] pyrene (BaP) is the most 
widely studied compound based on its carcinogenic character whose limit value has 
been defined for various matrices. The maximum limit of BaP for drinking water is 
0.01 μg/L. Additionally, the annual mean limit and 24-hour limit in air are 
0.01μg/m3 and 0.0025 μg/m3.  
         Short contact   Long-standing contact 
-Impaired lung function and 
coronary heart conditions as 
consequence of inhalation 
-Intake of water contaminated with 
PAHs has resulted in diarrhea, 
vomiting and nausea conditions. 
- When the human skin is exposed to 
PAHs, it results in irritation, swelling 
and allergic reactions of the skin 
[141-143] 
-Detrimental effects on the reproductive 
and development systems. 
- Kidney and liver infection, 
-Cataract inducement 
-Jaundice. 




 Figure 1.11: Structure of selected PAHs. Highlighted compounds comprise the Environmental 
Protection Agency (EPA) list of 16 priorities PAH [149]. 
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1.9.2 Analysis of PAHs 
Presently, the common traditional analytical methods used to detect PAHs include, 
gas chromatography/mass spectrometry (GC/MS), including chemical ionization 
MS, ion trap MS, TOF/MS, and isotope-ratio MS (IRMS), and high-performance 
liquid chromatography (HPLC) with fluorescence detection or ultraviolet detection 
(HPLC/UV). There are several advantages that are associated with the use of these 
standard analysis techniques, such as accuracy, reliability, and sensitivity. They 
present, however, some limitations. Some of these disadvantages include the fact 
that their processes involve high-risk loss of analytes during sample separation, in 
addition to using an extensive amount of hazardous organic solvents. With the 
various limitations of the traditional chromatographic techniques, there is demand 
for low-cost, sensitive, rapid, on-site, environmentally as well as human friendly 
techniques that can be carried out by public healthcare providers and institutions 
who are keen to improve the quality of water. Thus, this is where new emerging 
techniques like immunoassay come in [150,151].  
 
Lux et al. [152] pointed out that these methods require sophisticated equipment and 
present a lack of real-time detection.  When studying several groups of PAHs 
simultaneously, the extraction process can be complicated when PAHs of similar 
properties are included in the sample, as similar characteristics make the 
identification process difficult [153]. Molaei et al. [154] note that alternative 
approaches, such as single-drop microextraction, solid-phase microextraction, and 
stir bar sportive extraction methods have been introduced to reduce costs, pollution, 
and shorten processing time.   
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Manoli et al. [155] discussed a new model of magnetic solid-phase extraction 
(MSPE). The MSPE process uses magnetic material as adsorbents and comes with 
several advantages, including the ability to detect PAHs in crude samples. For 
decades, using a highly reliable GC-MS method solved the difficulty of detecting 
PAHs in crude samples. However, GC-MS has its limitations. Generally, even 
though GC-MS is extremely precise and sensitive, it involves very expensive 
equipment and is therefore not available to all laboratories or consumers 
[156].   Additionally, there has been an increasing demand for low-cost, sensitive, 
rapid, and on-site detection techniques by public health care providers and 
institutions who are keen to improve the quality of water [153] and want to 
understand the mechanisms of creation of PAHs in the environment. In addition to 
conventional PAH detection methods, the impact of pollutants on environmental 
water have been monitored using biological systems, including biomarkers and 
biomonitors [157].   
 
These biological techniques can measure the impact of anthropogenic activities in 
order to ensure compliance with environmental guidelines and regulations [158]. 
Biomonitoring involves the use of indicator organisms, for instance, filter-feeding 
mollusk bivalves [159,160]. As such, this technique is important because it can 
identify the early presence of water pollutants entering water sources [161-164]. On 
the other hand, biomonitoring can only be used to detect the presence of pollutants, 
not to identify or quantify a specific pollutant in water [165]. As a result, 
biomonitoring is limited in its application, and compared to other state-of-the-art 
methods such as immunoassay techniques, does not provide a persuasive 
performance [166].  
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A range of immunological assays including imunosensors, fluorescent and 
chemiluminescent immunoassays and Enzyme Linked Immuno Sorbent Assays 
(ELISA) have been developed for the analysis of PAHs. Immunosensors are created 
through the integration of immunoassay methods in micro-devices. As a compact 
analytical device, an immunosensor presents a surface where antigen-antibody 
complex can be detected and also converted into electrical and biomechanical 
signals using transducers. The final detected signals can then be processed, 
recorded and displayed [167].  
1.9.3 Surface Functionalisation Techniques                         
In relation to state of the art techniques, Ahmad and Moore [168] reported on the 
performance of an electrochemical immunosensor for the detection of 
benzo[a]pyrene (BaP) in water samples. Detection was done electrochemically by a 
common reaction used to create an electrochemical signal in immunological 
reactions, produced by the substrate para-aminophenyl phosphate (pAPP) (an 
example of an immunoassay with a pAPP reaction is shown in Figure 1.12).  In this 
reaction, an alkaline phosphatase enzyme [AP], which was linked to a secondary 
antibody, was reduced (by hydrolysis of the substrate pAPP) to para-aminophenyl 
[pAP], freeing hydrogen ions in the process. The difference in potential created by 
the two hydrogens was then measured, as it an electrical signal proportional to the 
presence of the target analyte. The same authors also used surface functionalization 
techniques like optimization of surface substrates and active redox probes to 
increase the sensitivity of the sensor. 
54 
 
Figure1.12:  Electrochemical detection using an immunological reaction by measuring the alkaline 
phosphatase (AP) enzymatic reaction towards the substrate para-aminophenyl phosphate (pAPP). 
Two electrons were generated with a new product (para-aminophenyl (pAP)) [168]. 
 
There are several possible surface functionalisation techniques for improving PAH 
detection. However, the current section will focus on three key approaches that are 
widely discussed in the literature in terms of improving immunosensor 
performance. These surface functionalisation techniques include optimisation of 
substrate surface reaction, redox-active probes and layer-by-layer technique.  In 
optimisation of surface substrates focuses on improving the sensitivity and 
selectivity of immunosensors by enhancing antigen-antibody binding and 
enzymatic reactions [169]. For example, the authors of [170] used a biocompatible 
polyaniline (PANI) layer and iron oxide to develop an electrochemical 
immunosensor platform for sensitive detection of benzo[a]pyrene (BaP).  
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The role of Fe3O4/PANI on a Nafion/ITO surface is to capture the BaP antigen with 
the aid of glutaraldehyde.  Fabricated Multi-HRP-HCS-Ab2 labels were added at 
the end of the assay (see Figure 1.13). The technique works through 
immunoreaction between the BaP antigen and the primary antibody (Ab1) in the 
sample solution.  The authors reported a linear response in the range of 8 pM to 2 
nM and a detection limit of 4 pM, which is highly sensitive, compared to 
conventional PAH detection techniques. 
 
Figure1.13: Schematic representation of Fe3O4/PANI/Nafion-based immunosensor using multi-
HRP-HCS-Ab2 bioconjugates as labels [170].  
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Redox-probes offer efficient PAH detection in polluted water as indicated in Figure 
1.14. In PAH detection, the objective of this technique was to amplify the redox 
cycling provided by the probes in order to obtain high electrochemical signals. The 
use of redox probes is useful as it can simultaneously detect multiple PAHs [171]. 
Figure 1.14 shows how a ruthenium tris(bipyridine)-pyrene butyric acid conjugate 
(PAH-Ru) was synthesized as a redox-labelled tracer [171]. For the PAH-Ru 
conjugate to be used as a tracer in PAH immunoassays, it needs to be detected by 
anti-PAH antibodies. 
    
      Figure1.14: Synthesis of ruthenium tris(bipyridine)-pyrene butyric acid (PAH-Ru) conjugate  
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1.9.4 Haptens and their conjugates 
The molecular weight of the PAHs is low and hence fails to induce an immune 
response. Thus, these molecules have to be conjugated to large carrier proteins with 
the aim of generating an immune response. However, the main drawback with the 
PAHs molecules is that they do not form covalent bond easily with the carrier 
molecules. Thus the PAHs are converted to haptens that easily form the required 
covalent bond with the carrier protein. The various haptens required for producing 
different antibodies are shown in figure 1.15 [172-173]. 
  


















                 Figure 1.15: Various haptens required for producing different antibodies 
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1.9.4.1 Pyrene as Hapten 
Pyrene that has been found abundantly in the environment consists mainly of 3 to 5 
fused aromatic rings. Based on this, the pyrene molecule that contains 4 fused rings 
called 4-ring pyrene, has been considered as the standard hapten for immunoassays. 
Additionally 1-pyrene butyric acid, which is also a 4-ring pyrene, is available 
commercially, and can be conveniently conjugated to carrier proteins. Thus, the 
additional work of derivatisation can be avoided.  The main aim of the study was to 
produce polyclonal antibodies by conjugating 1-pyrene butyric acid to carrier 
proteins and produce pAbs to be used in ELISA [173]. It was found that the Ab for 
PBA was more sensitive than PYR. Thus a monoclonal antibody was prepared 
using PBA and applied for detection of some other poly aromatic hydrocarbons in 
water [174].  
1.9.4.2 Benzo[a]pyrene as Hapten 
Benzo[a]pyrene has been used widely as target analyte as it is very toxic in nature. 
The derivatives of benzo[a]pyrene have to be synthesised in the laboratory as they 
are not commercially available. Recently, the metabolites of benzo[a]pyrene have 
been identified in urine with the help of immnunological assays for which two 
monoclonal antibodies (4D5 and 10C10) were produced with the hapten of 
benzo[a]pyrene-6-isocyanate (Figure 1.12) [175]. Another immunogen used for 
producing broad specific monoclonal antibodies BaP-13 and rigorous specific 
monoclonal antibodies 22F12 is benzo[a]pyrene butyric acid [176, 177]. Bap-13 
was obtained from 1-benzo[a]pyrene butyric acid which was specific towards to 21 
parent poly aromatic hydrocarbons along with its 10 derivatives [176]. 22F12 
antibody was the most selective and sensitive Ab to 6-benzo[a]pyrene butyric acid, 
7-benzo[a]pyrene butyric acid or 10-benzo[a]pyrene butyric acid. 
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The LOD for benzo[a]pyrene was 24 ng/L [177]. Another recent report provided a 
detailed study about where mice were immunised with 10-benzo [a] pyrene butyric 
acid –protein conjugate and 110 obtained by hybridoma cell lines were detected by 
a new biochip noncompetitive direct chemiluminescence immunoassay [178]. The 
hapten of benzo[a]pyrene butyric acid was used for development of single chain 
variable antibodies against the poly aromatic hydrocarbons [179]. Also another 
hapten synthesized for benzo[a]pyrene was 6- benzo[a]pyrene carboxaldehyde-O-
carboxymethyloxime. The limit of detection was 0.5µg/L for the time resolved 
fluoroimmunaassay of this hapten in water [180].  Another two synthesized haptens 
were 9,10-dihydrobenzo [a] pyrene-7 (8H)-one—7-(O-carboxymethyl) oxim and 1-
hydroxy pyrene used for immunoassays of urine [181, 182]. 
1.9.5 Proteins  
Proteins can quickly lose their shape and hence their activity upon functionalisation 
and attachments. Physicochemical properties of the protein and the surface play a 
key role when the procedure to modify the surfaces has to be taken. The recognition 
of proteins using antibodies primarily relies on the retention of binding affinity. 
Consequently, advanced strategies are needed to protect the bio-detection 
component [183]. After extensive examination, the immobilization of antibodies (or 
their fragments) on stable structures is broadly used in the life science zone. The 
successful application of antibodies to immunoassay-based uses is aided by the 
existence of necessary parameters. These parameters have various characteristics, 
such as antibody size, labeling, immobilization ability, sensitivity, selectivity, 
orientation, and stability. However, the capture and the detection of antibodies is a 
critical aspect for assay advancement, and the technique adopted may have 
considerable impacts on the assay. The capacity to design more sensitive and 
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reliable methods is dependent upon improvement of assay-specific antibodies to 
boost these general performance properties. The ability to improve antibodies with 
regard to modification and suitability for the applications is vital to robust biosensor 
advancement. Similarly, knowledge-driven methods to enhance surface chemistry, 
conjugation, and immobilization are critical to the development of the next 
generation of immunoassay methods. Research on antibody immobilization has led 
to the evolution of numerous mechanisms, which facilitate the introduction of 
sophisticated study tools and systems for better analysis [184, 185]. Therefore, the 
current antibody-based immunoassay platforms are better than traditional analytical 
approaches. In a typical situation, antibodies are deposited evenly on a solid surface 
in high amount and with the required orientations, such that they retain their 
effectiveness and avert non-specific bindings.   
 
The deposition of the active antibody onto the assay surface is essential in matching 
the reporter molecule to the secondary antibody.  The orientation and the activity of 
the antibody on the immunoassay surface depend on the mode of antibody 
immobilisation. Therefore, the quantity and activity of the immobilized antibody 
affect the immunoassay’s sensitivity [186]. There are two essential modes of 
antibody immobilisation, passive and covalent attachment. These modes rely on the 
antibody and the chemical properties of the solid phase upon which covalent 
immobilization is required [187]. The absorption of proteins on the substrate is one 




Figure1.16: Coupling approaches for linking antibodies to surfaces. In its natural state an antibody 
has primary amines, carboxyls and hydroxyls as target groups for antibody immobilisation. Amine 
group is the most abundant of all native pendent groups on an antibody. Carboxyl group is another 
viable group for antibody functionalisation. 
 
However, the success of this approach depends on random orientation and 
denaturation.  For crosslinking antibodies to the surface the availability of the 
functional reactive groups on both the partners is needed. The strategy of antibody 
immobilization influences the orientation on the surface, which eventually affects 
the activity of the antibodies. Thus, effective immobilisation of antibodies for all 
immunoassay methods needs novel and well-designed modes to maximize the 






1.9.6 The conjugates of carrier proteins  
The most common carrier proteins in the conjugation with haptens are ovalbumin 
(OVA), keyhole limpet hemocyanin (KLH) and bovine serum albumin (BSA). The 
hapten derivative containing functional groups like thiol, amine, hydroxyl and 
carboxylic acid are bonded covalently to the carrier proteins by using different 
techniques [188]. This binding step is very significant as the efficiency and quality 
of the antibodies depend on the binding ratio of the hapten-protein conjugates in the 
immunoassays. The strength and specificity of the immune response is dictated by 
the ratio of the hapten to the carrier protein. The average ratio of binding of haptens 
to carrier protein is analysed by various techniques, such as gel electrophoresis and 
matrix assisted laser desorption ionization time of flight mass spectrometry 
(MALDI-TOF-MS) [189, 190].  These techniques can estimate the binding ratio 
accurately. No technique currently exists for estimation of all the hapten-protein 
conjugates. It was reported that the synthesis, characterization and the calculation 
of the binding average of PBA-OVA and PBA-BSA were by MALDI-TOF-MS, IR 
and UV –visible spectroscopy [191]. These two methods were very useful to 
determine the binding ratio of the haptens to the carrier protein. Immunological 
assays are highly selective and sensitive and relatively inexpensive. These 
immunoassays are used for the analysis of both broad specific and class selective 
PAHs [192]. The PAHs present in biological samples, soil and water can be 
detected with the aid of commercially available ELISA kits [193,194]. Sufficient 
antibodies are required for the analysis of PAH by immunoassays. However the 
search for novel antibodies for immunoassays, equipped with quantitative structure 





Toxic compounds present in the environment consist of different poly aromatic 
hydrocarbons, so it is essential to establish a technique that can identify different 
poly aromatic hydrocarbons simultaneously. Recent reports indicate that the generic 
antibodies or specific antibodies can be analyzed using multi tracer co-marking or 
multi antibody coating with the help of ELISA [195]. Structural activity 
relationship is a relationship between a biological activity of a molecular system 
and its geometric and chemical characteristics (electronic and crystal structures of a 
molecule). The multi analyte ELISA is based on the technique of cross reactivity of 
the broad specific antibodies to different poly aromatic hydrocarbons since there is 
a structural similarity between the different poly aromatic hydrocarbons. Data 
pertaining to the cross reactivity of different poly aromatic hydrocarbons has still 
not been completely investigated. Molecular modelling as well as Quantitative 
Structure-Activity Relationship (QSAR) has been used extensively in the 
immunoassays relating to the environment for understanding the physical and 
chemical interactions of haptens and antibodies [196-201]. These interactions have 
been studied by both two-dimensional and three-dimensional QSAR studies 
including comparative molecular field analysis [200,201], regression analysis 
[197], principal component analysis and Hantzch method [199]. The different 
analogues of poly aromatic hydrocarbons and their cross binding to different 
antibodies have made them suitable candidates for QSAR studies. An ELISA kit 
has been developed for the QSAR studies relating to poly aromatic hydrocarbons 
[202]. An ELISA study of quantitative structure and cross reactivity relationship of 
polycyclic aromatic hydrocarbons was conducted. The study was done with the aid 
of published data on multiple regression analysis and comparative molecular field 
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analysis [203,204]. The main aim of the study was to investigate the effect of 
molecular property on the cross reactivity of ELISA and the probable cross 
reactivity of QSAR studies. The results indicated that the major factors that affected 
the immunoassays of polycyclic aromatic hydrocarbons were their hydrophobic 
property and solubility. Additionally it was found that the cross reactivity can be 
effectively predicted by QSAR studies. However there are certain fundamental 
problems associated with QSAR that still need further attention to be solved [205].  
Another study reported a modified method for analysing the binding of haptens to 
monoclonal antibodies through the use of homogeneous modeling and ligand 
docking [206]. A three dimensional model of the variable fragments of the 
antibodies was constructed on the high resolution crystallographic structures in 
order to study the factors responsible for binding affinities of monoclonal 
antibodies and the haptens. This is a promising method for studying the interactions 
between antibodies and haptens. Antibodies play a significant role in 
immunoassays for haptens of low molecular weight in immunoassays. There is still 
a dearth of information about haptens and antibodies for polycyclic aromatic 
hydrocarbons. Interdisciplinary work between synthetic chemists and 
immunological chemists will provide greater insights in this arena and synthesise 
high quality antibodies. There is a wide scope for developing broad spectrum, 
monoclonal, polyclonal, conventional and novel antibodies for use in the 
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Immunoassays measure the presence of target that is present at low 
concentration. The focus of this chapter is on the immunoassay of PAHs. 
Immunoassays use bioanalytical processes in the detection of analytes, such as 
lipids, carbohydrates, and proteins in solutions by means of the interaction of an 
antibody (immunoglobulins (Ig)).  
2.2  Objective  
The main aim of the presented work was to study an immunoassay method based on 
(ELISA) for the detecting of PAHs in environmental monitoring of drinking water. In 
particular, the research focused on measuring the presence and concentration of (BaP) 
in drinking water. Heterogeneous immunoassays were used for all ELISA formats. 
Incubation and washing steps were conducted in heterogeneous immunoassay multiple 
mixing. The properties of the analyte to be detected and the sensitivity of the assays 
must be considered in order to carry out the competitive or non-competitive assays. In 
this study the heterogeneous immunoassay was subdivided into competitive or non-
competitive assays. With regard to competitive assays, the labelled antigen and the 
antigen to be analysed compete to attach to the immobilized antibody. In non-
competitive assays, the antigens bind to the excess of the immobilized antibodies, 
which are on the solid surface and are detected after binding to the secondary 
antibodies. The typical response curves for these assays can be directly or indirectly 
proportional to the concentration of the antigen in the sample. The optimisation of 
different reagents and conditions was carried out to ensure the accuracy, sensitivity 
and specificity of the immunoassay assays.  To immobilise the immunoreactants, the 
assays took place in a 96-well ELISA microplate.  
The ELISA microplates were used as solid surfaces for immunoreactions. The 




of plate was used in order to minimize edge effects and to ensure optimal optical 
conditions for data collection. The antigens were screened via ELISA technique 
using the 96-well ELISA plat reader. The detection approach used was an enzymatic 
labeled signaling system. Colourimetry technique was used to measure the yellow 
coloured product in a solution. Upon enzymatic reaction, chromogenic substrates 
produced coloured compounds. Spectrophotometer (absorbance plate reader) at 405 
nm read the absorbance signal. The wavelength depends on the type of the substrate 
and the enzyme label used in the ELISA technique. In this study a p-nitrophenyl 
phosphate (pNPP) substrate and an alkaline phosphatase (AP) label enzyme were 
applied for all optical assays. A p-nitrophenyl phosphate (pNPP) substrate is non-toxic 
and remains stable for many months at 40C .It is used for detecting alkaline 
phosphatase (AP) label enzyme in ELISA experiments. Alkaline phosphatase (AP) 
label enzyme has a high specific activity, stability for long periods in appropriate 
storage condition and inexpensive regent. Alkaline phosphatase (AP) label enzyme 
also has also a low background and reaction rates, which increases sensitivity over the 
incubation periods. The substrate chosen for detection of AP enzyme activity 
was pNPP that dephosphorylates into (pNP), a soluble chromophore with a maximum 
molar extinction coefficient at 405 nm under alkaline conditions.  
2.3 Experimental  
2.3.1 Materials:  
For the synthesis of BSA-PHEN coating conjugate: bovine serum albumin (BSA), 
adipic acid dihydrazide (AAD), phosphate buffered saline (PBS), 1-ethyl-3-(3- 
dimethylaminopropyl) carbodiimide (EDAC), diethanolamine dimethyl sulfoxide 
(DMSO), phenanthrene-9-carboxaldehyde, sodium cyanoborohydride (NaCNBH4) , 
sodium hydroxide were bought from Sigma (Dublin, Ireland). In order to adjust pH, 




(England) and sodium hydroxide (NaOH) was bought from Sigma (Dublin, Ireland). 
Monoclonal mouse antibody 4D5 specific to BaP was bought from Santa Cruz 
(Heidelberg, Germany). Sodium hydrogen carbonate, sodium chloride, detergent 
Tween-20, Tris salt, BaP, alkaline phosphatase (AP) labelled goat anti-mouse 
antibodies (whole molecule), a p-nitrophenyl phosphate (pNPP) substrate agent and 
diethanolamine reagent (DEA) were all purchased from Sigma (Dublin, Ireland). All 
reagents were of analytical grade or better and any water used in the solutions was 
nanopure water. A Micro BCATM Protein Assay Reagent kit was provided by Pierce 
(Rockford, IL). In order to ensure optical detection a standard 96 well ELISA 
microplate was bought from Greiner bio-one (Germany).  
2.3.2 Instrumentations: 
Slide-A-LyzerTM Dialysis cassettes 10K (0.5-3 ml) from Thermo Scientific were used 
for the purification of proteins. For ELISA applications, EL Read 2000 microplate 
reader was provided by biochrom.co.UK. For incubation, a Biometra OV3 Incubator 
(Gottingen, Germany) was set at 37 OC.  
2.3.3  Procedures. 
2.3.3.1 Preparation of phenanthrene-protein coating conjugate 
Bioconjucation is a method to link and combine two biomolecules to form a complex 
that can be used as a detecting probe in ELISA. The use of a coating conjugate was 
necessary because the small molecule Benzo[a]pyrene (BaP) is non-immunogenic, and 
therefore does not induce an immune response unless coupled with macromolecules 
such as bovine serum albumin (BSA) protein. Coating conjugate was a method to 
combine more biomolecules to form a complex that could be used as a detecting probe 
in the immunoassay.  
The preparation procedure of the coating conjugate (carbodiimide method) has been 




1) The BSA (carrier) was covalently coupled with the hapten phenanthrene-9-
carboxaldehyde and adipic acid dihydrazide (AAD) was used to activate the BSA 
agent. 
2) Adipic acid dihydrazide (79.8 mg) was dissolved in (2400 μl) phosphate buffered 
saline (PBS, pH 7.4) under a fume hood.  
3) 24 mg of BSA was mixed with 1386.4 mg of EDAC and added to the AAD 
solution.  
4) The resultant mixture was placed in ice and stirred for 4 h using a magnetic stirrer 
in the fume hood.  
5)  The coating conjugate solution was inserted into Slide-A-LyzerTM using a 
disposable syringe. Dialysis cassettes of 10kDa MWCO (0.5-3 ml) were used and the 
cassette were immersed in PBS buffer for 2 hours with 3 changes of fresh buffer of 
750 ml each.  
6) A volume of 1800 μl of the obtained conjugate solution was mixed with a freshly 
made dilution of phenanthrene-9- carboxaldehyde (0.6 mg) in 1200 μl dimethyl 
sulfoxide (DMSO), and was left to react for 2 hours at room temperature under the 
fume hood.  
7) A preparation of 24 μl of NaCNBH4 (5 M) in NaOH (1 M) was then added to 
the solution previously obtained and left to mix for 1 hour. This solution was purified 
in a dialysis cassette as explained in the previous step.  The resultant solution was the 








Figure 2.1: Schematic of preparation of coating conjugate. The crosslinker EDAC helps the coupling   
of AAD with the BSA hydroxyl group. This combination provides the coating conjugate with amine 
groups, where finally hapten phenanthrene-9- carboxaldehyde binds.  
 
2.3.3.2 Matrix Assisted Laser Desorption ionization / mass spectrometer 
(MALDI-TOF /MS) test for determination of the average PHE to BSA ratio:  
• Required items:  
1)  A sample to be analyzed (a coating conjugate BSA-PHEN).  
 A matrix substance -Cyano-4-hydroxycinnamic acid (Bruker Matrix HCCA).    
-Cyano-4-hydroxycinnamic acid was used as matrix in developing the detection of 





• Principle:  
Matrix Assisted Laser Desorption ionization / mass spectrometer (MALDI-TOF /MS) 
is a soft ionization method where the sample (a coating conjugate BSA-PHEN) is 
mixed in a matrix (Bruker Matrix HCCA) and then the matrix absorbs the laser light 
energy at a certain wavelength (Figure 2.2). The wavelength is dependent upon the 
type of the sample. The matrix transforms the laser energy into excitation energy, 
which then heats the surface of matrix. The result from the heating surface is photons 
and then collect, analyze and detect the resulting ions.  
Figure 2.2: Mass analyser- Mechanism of TOF where separates ions according to their mass (m)-to 
charge (z) (m/z) ratios 
 
• Sample preparation required: For the measurements of the coating 
conjugate ratio.  
The first step was synthesis of coating conjugate (BSA-PHEN) as it described in the 
previous section (from step 1 to step 5). From the step 6 a five different concentrations 
were prepared. A volume of 1800 μl all of the obtained conjugate solution was mixed 
with a freshly made dilution of phenanthrene-9- carboxaldehyde (C1=0.5, C2=0.125, 




It was left to react for 2 hours at room temperature under the fume hood.  As in step 7 
the same process was done for all dilutions.  
•  The protocol of MALDI-TOF / mass spectrometry (MS) test.  
The first step of the MALDI preparation was to mix the sample and matrix solutions 
in a suitable ratio. The matrix was able to embed and isolate the sample. The selection 
of the matrix was suitable for the molecular weight of the protein to be analyzed. The 
aliquoted samples were defrosted and mixed on the target plate as a thin film. 1µl was 
taken from each sample and allowed to dry at room temperature. (If the matrix was not 
added to the sample within 30 min it could not be used).  The sample was overlaid on 
sample spot with 1ul of HCCA and allowed to dry. A homogeneous preparation had 
to be observed. MALDI-TOF-MS samples were examined using the Broker Biotyper 
Microflex LT. The samples were analyzed using flexcontrol software. The mass range 
used was 19 kDa to 121 kDa. The samples were analyzed in a linear mode (4.4 x 
2776v). The mode of ionization was singly charged ions. Positive ion detection was 
used because of the sample had a protein with a functional group (amines). Positive 
ion detection is where the sample accepts a proton (H+). Various frequencies of the 
laser to detect any peaks were applied; the frequency of 240Hz was where it found the 
information. There were 240 shots added for each successful run.   
2.3.3.3   Immunoassay buffer solutions:  
Suitable buffer solutions for immunoassay development in this research were 
produced in house to minimize non-specific binding. Buffers were used to protect the 
proteins activity against degradation or denaturation of the material. Antibodies may 
bind to other proteins with lower affinities. These non-specific interactions can be 
removed by a number of different approaches. The addition of surfactants approach 
such as Tween-20 decreases hydrophobic interactions. Non-specific binding and 




can help to remove this background noise. 1 M HCL and 1 M NaOH were used for 
adjusting the pH of all buffers.  
2.3.3.4 Checkerboard ELISA protocol of immunoassays regents:  
A checkerboard ELISA involves different dilutions of each reagent used against each 
other on the microplate wells in order to obtain the optimal dilution values of reagent 
concentrations (Figure 2.3). The capture was a mouse monoclonal and the detection 
antibody was an anti-mouse secondary antibody. The species of capture antibody is 
raised and should be different from the species of our sample. The species of these 
antibodies were different in order to prevent cross-reactivity from the detection 
antibody with sample. A capture antibody always binds to the target antigen; therefore, 











Figure 2.3: checkerboard capture assay was performed with different concentration of the capture 
antibody and the detection antibody. Each column 1-12 contains a capture antibody dilution factor. Each 
row A-H contains a detection antibody dilution factor. 
 
• Reagents required:  
1) The detection limit of the assay depends on the affinity of the chosen antibody. The 






sensitive detection. Monoclonal mouse antibody (4D5 specific to BaP) was used at the 
desired concentration in bicarbonate/carbonate buffer (10 μg/ml). The recommended 
coating concentration should be between 1 to 10 μg/ml because of the protein-binding 
capacity of 100-400 ng/cm2. ELISA plate captures around 100–400 ng of IgG/cm2. This 
is commercially available as high-binding plate. Typical coating conditions involve 
adding 50-100 μl of buffer, containing antigen or antibody at a concentration of 1-
10 μg/ml, and incubating overnight at 4°C or for 1 hour at 37°C.   
2) Detection antibody (alkaline phosphatase (AP) labelled goat anti-mouse 
antibodies) was at desired concentration 1/1000 dilution.  
3) Washing buffer (Tris 50 mM+0.05 % Tween 20). Tween-20 reduces nonspecific 
binding by blocking unreacted sites and retaining protein structure. 
4) Blocking reagent (1% BSA in Tris 0.05M buffer solution) was used to reduce 
the non-specific binding of detection antibodies to the plate surface itself. The 
blocking buffer had an unrelated protein that did not react with any of the 
antibodies that were used in the detection step.  
5) Colour producing substrate (a p-nitrophenyl phosphate (pNPP) substrate agent 
in DEA buffer 0.1 M). Diethanolamine (DEA) buffer has favourable reaction kinetics 
and good sensitivity compared to most buffer immunoassays.   
6) Incubation times of 1 hour at 370C, or overnight at 40C or of 2 hours at room 
temperature to ensure optimal performance and reproducibility of the assay.  
• The protocol of checkerboard ELISA 
1) Bicarbonate/carbonate buffer (100 μL) was added to each well of the microplate. 
Then, using a multichannel pipette. 100 μL of the capture antibody solution into each 
well in column 1. The solution was pipetted up and down in order to mix it correctly. 
Using new tips, 100 μL from each well in column 1 was added to column 2. This 




Column 12 was a positive control (no capture antibody). 
2) The plate was incubated at 37◦C for 1 hour in order to allow the capture antibody 
to bind to the microplate. Adsorption took place passively due to hydrophobic 
interactions between the amino acids side chains on the capture antibody used for 
coating and the microplate surface. It was key to put the plate in a moist condition 
in order to minimise evaporation.  
3) The volume of blocking solution used was 250 μl. This was incubated at   37◦C for 
1 hour in order to fully block the plate. 
4) The plate was washed with 3XTris (300 μl) per well. The microplate was blotted 
dry using clean tissue.  
5) 100-μl blocking buffer solution was added to all the wells in the 96-well plate. In 
this stage the previous blocking buffer, which was used for the blocking step, was also 
used to dilute the detection antibody.  
6) The detection antibody was diluted in a separate vial before being added to the plate. 
100 μL of the detection antibody solution was added into each well in row A. The 
solution was pipetted up and down in order to mix it correctly. Using new tips, 100 μL 
from each well in row A was added to row B. This process was repeated until row G 
was reached. Row H was a negative control (no detection antibody). 
7) The microplate was incubated and washed. A p-nitrophenyl phosphate (pNPP) 
substrate agent was added, a signal was generated and the absorbance of the solution 
in microplate was read on EL Read 2000 microplate reader at the wavelength 405 nm.  
2.3.3.5  Optimisation of AP Labelling  
The aim of this experiment was to develop an optical immunoassay using the 
microplate for optimising of AP labelling. The monoclonal mouse antibody 4D5 
specific to BaP at desired concentration was incubated at 37◦C for 1 hour in 




microplate was blocked by blocking solution and incubated at 37◦C for 1 hour and 
washed. Six different dilutions (1: 1000, 1:3000, 1:5000, 1:7000, 1:9000 and 1:11000) 
were prepared in triplicate (n=3) in order to maximise the optimal dilution for the 
immunoassay. The plate then was incubated at 37◦C for 1 hour and washed. The final 
step of the immunoassay was the addition of (pNPP) substrate agent; microplate reader 
at the wavelength 405 nm generated the signal. The optimal dilution was chosen for 
carrying out the further immunoassays.   
2.3.3.6 Antibody immobilisation time  
This experiment was carried out in order to achieve the optimal immobilization time 
of monoclonal mouse antibody 4D5 specific to BaP (capture antibody) at the desired 
concentration onto the microplate. Five different immobilization times (20 min, 30 
min, 40 min, 50 min and 60 min) between the monoclonal mouse antibody and the 
plate were tested in triplicates (n=3) in order to optimize the immobilization time of 
the immunoassay. The plate was incubated for 1 hour at 37oC. Then the detection 
antibody solution (1/3000) was added. As was the case with the all the pervious 
experiments, the final immunoassay steps were repeated.  
2.3.3.7 Capture assay: monoclonal mouse antibody 4D5 specific to BaP   
concentration:  
50 μl of the previously obtained coating conjugate (BSA-PHEN, concentration 6.0 
μg/ml) was added to each well of the microplate and allowed to bind for 60 minutes at 
37 oC. The microplate was washed with Tris 0.05 M + 0.05 % Tween 20 (pH 7.4) three 
times to remove any unbound coating, and dried on a clean tissue. 200 μl of blocking 
solution Tris 0.05 M (pH 7.4) was added to all wells of the microplate to reduce 
background interferences. The treated wells were left to incubate for 60 minutes at 37 
oC. The wells were washed with Tris 0.05 M +0.05 % Tween 20 (pH 7.4) 3 times to 




serial dilution of monoclonal mouse 4D5 antibody in 10 different concentrations was 
prepared. 50 μl of each concentration was applied to the wells and allowed to bind for 
60 minutes at 37 oC. The wells were washed with Tris 0.05M +0.05 % Tween 20 (pH 
7.4) 3 times to remove unbound materials of previous step and dried on a clean tissue.  
Finally, 50ul of AP labeled antibody dilution (anti-mouse IgG, 1/3000 dilution) were 
added to each well of the microplate, and the wells were incubated for 60 minutes at 
37 oC.  
Before the incubation, the wells were washed with Tris 0.05 M +0.05 % Tween 20 
(pH 7.4) three times and dried on a clean tissue. After the last step of the capture assay 
was completed, the microplate was introduced to the spectrophotometric reader.  
Absorbance was measured for the AP label reaction and a solution of the substrate 
pNPP in Diethanolamine buffer (DEA, 0.1 M, pH 9.5) at 405 nm. The optimal 
concentration was chosen to carry out the immunoassays.  The diagram for capture 







                           
                                         Figure 2.4 Capture assay 
 
2.3.3.8 Displacement assay on microplate:  
In this assay the target analyte binds to the primary antibody (in our case 4D5 mAb) 







      




in the wells will attach to the secondary antibody, in our case the AP labelled anti-IgG. 
Optimized values of each reagent concentration (see previous sections) were carried 
out for each well.  A serial dilution of the analyte under test (BaP in DMSO) was 
prepared by using blocking buffer (Tris 0.05 M). Three replicates were carried out for 
each concentration of BaP (n=3).  The prepared microplate was introduced to the 
spectrophotometric reader in order to measure individual responses at 405 nm. The 






                                   
                                    Figure 2.5: Displacement assay 
2.3.3.9 Use of a spiked sample  
Drinkable water was collected from LSI lab in Tyndall national institute. Sensitivity 
of the assay was measured by analysing a triplicate of water sample using a 
displacement assay. For recovery experiment, the known amount of BaP was spiked 
in the tap water sample. Spiked sample was prepared in blocking solution at three 
different dilutions; 10,50,100 ng/ml of BaP. 
 
2.4 Results and Discussion:  
2.4.1 Development of immunoassay protocol  
   The main aim of this work was to develop an optical immunoassay using microplate 
for the detection of Benzo[a]pyrene (BaP) in drinking water. In this study, 
optimizations of different reagents were performed on the wells in order to obtain the 
 
 
    









optimal concentration for a maximum antibody-antigen affinity. We chose a 
displacement assay form as it allowed us to reach low limits of detection and to obtain 
good assay sensitivity. This format is commonly used when the antigen is small and 
non immunogenic. Optimisation of immunoassay working reagents was individually 
done and then studied the response of the system before reaching the saturation. 
Optimisation of the assay was achieved through using the following criteria: 
concentrations of coating conjugate, checkerboard ELISA, antibody immobilisation 
time, optimisation of AP labelling and optimisation of monoclonal mouse antibody 
concentration: The following subsections will describe the results obtained in detail 
and link it to the final displacement assay used. 
2.4.2   Optimisation of buffer solutions  
In the previous immunoassay research conducted by our group, the influence of several 
immunoassay parameters was prepared and studied in order to obtain the optimal 
conditions for the immunoassay measurements. These include the pH of immunoassay 
buffers, incubation time and the PAH solvents. In addition, the optimum concentration 
of each immunoreactant has been studied resulting in maximum antigen-antibody 
affinity reactions. In this research the same immunoassay buffers and conditions were 
utilized and results were as predicted. The most suitable blocking solution buffer was 
1% BSA. It showed a good ability to block the free sites on the solid surface. The 
presence of the blocking agents can reduce the steric hindrance and denaturation of the 
proteins bound to the surface. PAH is insoluble in water and lipophilic compound and 
for dilution PAHs the most suitable organic solvent found was DMSO. It showed a 
better response with a high sensitivity and limit of detection when studied in 
comparison with different organic solvents such as acetone and methanol.  In order to 
achieve the maximum enzyme activity, the enzyme used in this research worked best 




2.4.3   Optimisation of coating conjugate  
 
The concentration of the carrier protein BSA was determined using A Micro BCATM 
kit. The concentration of the protein sample was determined on a 96 well ELISA 
microplate. The typical behaviour of a standard protein curve measured at the 
wavelength 590 nm means that, if the carrier protein concentration increases, the 
absorbance (optical density) would increase linearity (Figure 2.6). The concentration 
of BSA sample in the ready coating conjugate was calculated based on the standard 












         Figure 2.6:  The serial dilution of the protein sample was performed on a 96 well ELISA 
microplate. The typical behaviour of a protein curve measured at 590 nm (n=2). 
 




























The concentration of the hapten was measured by using the UV spectroscopy at 532nm 
(parameters: start wavelength = 200 nm and the end wavelength = 450 nm, the scan 
step = 1.0 nm, the scan speed = 500 nm/min, temperature was off, run mode = standard, 
repeat time =30 and (n =3).  
 










                        Figure 2.7: The typical behaviour of a PHEN curve measured at 532 nm 
 
The average hapten to carrier protein ratio was manually calculated as 16.45 molecules 
of hapten per molecule carrier protein for the prepared coating conjugate.  It is critical 
for a successful immunoassay to use an optimized concentration for the coating 
conjugate. As mentioned earlier, hapten needs to couple with macromolecules such as 
bovine serum albumin (BSA) protein, in order to take part in an immunogenic reaction. 
In our experimental work, we optimized this value by working with a serial dilution of 
the coating conjugate. This was done in order to ascertain which value produced the 
maximum output signal without reaching saturation. We used a standard ELISA plate 
and measure the absorbance as a response. The final value that was used for the 





2.4.4 (MALDI-TOF /MS) test for determination of the average binding PHEN to 
BSA   ratio:   
MALDI-TOF experiment was done before being used for the immunisation and assay 
purposes. The selection of the conjugation method was governed by the functional 
group of the hapten. The method was useful for monitoring the conjugation for specific 
antibody against analyte of interest [2-4]. The most used carrier protein for conjugation 
is (BSA). BSA has a large number of functional group available for hapten 
conjugation; BSA solubility in buffers is high above pH 5.5 due to its low molecular 
size. There has been huge progress in recent years in protein-hapten conjugates for the 
antibody's response with applications in immunoassays for environmental pollutants 
[5-8]. The phenanthrene-9-carboxaldehyde hapten was cross-linked (coupled) with the 
BSA carrier protein to obtain the immunogenic reaction. The complex of such 
conjugates had to always be stable and reproducible. This led to consistent hapten-
protein stoichiometries, resulting in small variations and desired immune response. 
Synthesis of the phenanthrene-9-carboxaldehyde hapten coupled with the BSA carrier 
protein was the most important factor for specific antibody against PAHs in optical 
immunoassay applications. The functional group of the phenanthrene-9-
carboxaldehyde selected the type of the conjugation technique to be carried out. 
Current methods apply amine, carboxyl, hydroxyl groups on the hapten and the protein 
[9,10]. It was important to study the prepared conjugates in order to measure the 
phenanthrene-9-carboxaldehyde density on BSA protein surface. The higher ratio of 
coating conjugate increases the intensity and quality of the immune response. 
However, there is a chance that a high density of substitution could negatively 
influence the performance of immune response produced [11]. In addition, the 
complex of coating conjugate is not always reproducible, even in preferable 




conjugate is an important factor in immune response generation. In this study, the 
hapten (phenanthrene-9-carboxaldehyde) was coupled to carrier protein (BSA). The 
binding efficiency of hapten-carrier conjugate was optimised by taking different 
hapten-carrier concentrations.  
Five different concentrations were prepared for immunization purpose.A volume of 
1800 μl of the obtained conjugate solution was mixed with a freshly made dilution of 
phenanthrene-9-carboxaldehyde (C1=1,C2=0.5,C3=0.25,C4=0.125,C5=0.062) 
mg/ml in dimethyl sulfoxide (DMSO) solvent. The Phenanthrene-9-carboxaldehyde 
[PHEN} was synthesized in the LSI laboratory at Tyndall National Institute for 
coupling with BSA protein. The BSA-PHEN conjugates prepared were characterized 
using the MALDI-TOF method at Cork Institute of Technology. The masses were 
analyzed twice. Unfortunately, in the first run, there were no peaks found in any of the 
concentrations.  
The procedure started adding a 1 µl from each different concentration on the sample 
spot area, which was then overlaid that with 1 µl of the matrix. The MALDI was set 
to analyze the sample between 3kDa and 20 kDa, i.e., the conventional range. The 
protein in our solution was greater than this range. The protein molecular weight used 
in the range of 66 kDa. The second run was done after receiving advice from the 
manufacture of MALDI on how to change the mass range in order to run the sample. 
The samples were run this time with a little more success. As was expected, there was 
no peak in the control PBS sample. Two samples (C1, C3) returned no peaks. These 
two samples were run a few times but still no peaks were obtained. The screenshot of 
the screen of the MALDI for the analysis of these two showed fuzzy lines. These were 
noises, and no definitive peaks; hence the lack of mass spectra. All samples were 
freshly prepared at the same time and under the same conditions. However, these 




Data for the other three concentrations (C2, C4, C5) was obtained and figure 2.7 showed 
their three peaks. In the Figure 2.6 the peaks found unusual in their mass spectra, it 
was expected to have only one peak for the hapten-carrier conjugate in each mass 
spectra. C20-A42 paint program shows the mass spectra for these three peaks. The 
clarity was poor and there was a lot of noise even after background noise subtraction.  
Figure 2.8: Determination of hapten density on BSA-PHEN conjugates using MALDI-TOF method  
 
The preliminary data below the conjugation density for each hapten in increasing 
concentrations (C2, C4, C5) resulted in a noticeable improvement in the molecular 
weight of the sample as determined by watching the peak change of mass spectra 
(Figure 2.8). The shift in molecular weight due to the combination of hapten molecules 
to BSA matched the number of hapten molecules per BSA molecule. Obvious coupling 




Table 2.1: Different coating conjugates concentrations. Control (PSB buffer) =0, MW (PHEN)=206.24. 
MW of     BSA =66430.3 kDa. 
 
2.4.5   Optimisation checkerboard ELISA titration assay  
In order to achieve the best results, the dilution factors of the two antibodies must be 
optimized. If the antibodies are too concentrated, these will saturate the assay. If the 
antibodies are not concentrated enough, the response will be difficult to measure. In 
order to attain a strong signal, we used a checkerboard titration for optimal concentration 
of two variables at once. The resulting combination was the working concentration. 
Each well was a different ratio of the two variables. Checkerboard titration was used 
only to acquire the optimal concentration of the two variables, but the optimal ratio of 
concentrations as well. From the checkerboard assay we could get information for the 
application used, and we got better results. A different pH was tested in columns and 
rows and antibody controls served as the background controls. In addition, optimal 
signal-to-noise ratio was determined for the ELISA assay.  
Variations in blocking conditions were optimised in the same plate. In this study, the 
checkerboard titration determined the optimal concentrations of monoclonal mouse 
antibody (4D5 specific to BaP) and the optimal concentrations of the detection antibody 
(alkaline phosphatase (AP) labeled goat anti-mouse) on the 96-well microplate.  
 












C2 0.5 68214.485 1784 8.65 (9) 
C4 0.125 67335.970 905.674 4.48(5) 




Capture ELISA assay was carried out to optimise the two antibodies concentrations. 
Serial dilutions of both components were titrated against each other on the plate. The 
higher the component concentrations were, the higher the optical density that was 
obtained.  Two appropriate positive (P) and negative (N) controls were used in the 
immunoassay plate in order to validate the results. Positive control was a sample that 
was known not to contain capture antibody I wish to detect. Positive control was applied 
to the wells resulting in the absence of signal from wells. A negative control is a sample 
that was known not to contain any detecting antibody I wish to detect. Negative control 
in the assay tested for the presence of non-specific binding. The optimum dilution 
factors were observed and used for the final assay. The dilution factor of the capture 
antibody was (1:64), where the concentration (0.0411μg/ml) and the dilution factor of 
detection antibody was (1:4). The concentration of detection antibody was (1:3000 
dilution). 
2.4.6   Optimisation of antibody immobilisation time  
The results obtained were reported in Figure 2.9. Low response values were measured 
when the incubation times of less than 60 min were used. The absorbance started to 
increase when the antibody was incubated for more than 20 min. In ELISA, the 
optimum incubation time for the adsorption of the antibodies to solid surface is 
important, with respect to the development of a rapid and fast assay. For this reason, 
the incubation period of the capture antibody was studied. Capture assay was 
performed for optimisation of the antibody incubation time. The results showed that 
the incubation time of 60 min at 37 0C is sufficient enough for the antibody binding, 
thus achieving a good response.  After 60 min the absorbance was higher than the 
recommended value of optical density (OD) range (less than 1.2 to 0.2), become 
constant and the reaction was concluded. 60 min was used as the minimum time 
















          
      Figure 2.9: Absorbance signals detected for different incubation times between the antibody and 
the solid surface. The points correspond to the average signal of absorbance ± S.D. calculated for 
n=3 repetitions.  
 
2.4.7   Optimisation of AP Labelling  
The results were reported in Figure 2.10. The typical response curve for this assay was 
directly proportional to the concentration of the antigen in the sample. The optical 
density (OD) values increased when the detection antibody dilutions increased. In 
dilution 1:1000 (0.001), the OD value reached to the steady state and showing that the 
antibodies were saturated. The enzyme-labelled conjugate dilution 1:5000 was used as 
optimal dilution to carry out the displacement assays. The chosen enzyme-labelled 




















Figure 2.10: Optimisation detection antibody dilution. The antibody immobilisation time of the antibody 
was 60 min. The dilution points correspond to the average signal of absorbance ± S.D. calculated for 
n=3 repetitions.  
 
2.4.8 Optimisation of monoclonal mouse antibody 4D5 specific to BaP 
concentration 
The aim of this experiment was to optimize the concentration of monoclonal mouse 
4D5 antibodies on the wells using capture format. This assay was developed by 
applying the coating conjugate (6.0 μg/ml) to the wells. The wells were blocked with 
1% BSA in Tris 0.05M, pH 7.4 solution. A serial dilution of monoclonal mouse 4D5 
antibody in 10 different concentrations was prepared and placed to the wells. An AP 
labelled antibody solution (1/3000) dilution was added to each well of the plate. 
Capture assay for antibody concentration measured after the exposure to the pAPP. 
Detection was absorbance (n=3). This assay was developed to measure amounts of 





Figure 2.11 illustrates the optimized concentration of monoclonal mouse 4D5 antibody 
before saturation level of the system. It was found that the optimal concentration was 















 Figure 2.11: Calibration curve obtained with the absorbance found for each concentration of the    
monoclonal mouse 4D5 antibody (7.8 ng/ml to 10 μg/ml) (n=3).  
 
 
In the graph the concentration of capture antibody (commercial 4D5 mAb) is on the 
log scale (X) and the absorbance signal at 405nm is on the linear scale (Y). The 
performance of the system shows the limit of detection (LOD), the linear range and 
the saturation area. The International Union of Pure and Applied Chemistry states that 
(LOD) expressed as a concentration CI (or amount, qI), is derived from the smallest 
measure, xI, that can be detected with reasonable certainty for a given analytical 
procedure. This is represented by equation (1).  
           𝐿𝑂𝐷 =
𝑘𝑠𝑏
𝑚





The value of k a numerical factor chosen in accordance with the confidence level 
desired. The use of k = 3 allows confidence level of 99.86% that a measured sample is 
greater than or equal to three times the average of the blank signal plus three times the 
blank signal plus three times the standard deviation of the blank signal. S is the 
standard deviation of the response and b is the slop of the calibration curve. It can be 
calculated for a linear calibration curve by the slope of the line (m), where the equation 
of the line is given by: 
                       𝑦 = 𝑚𝑥 + 𝑐                      Equation (2) 
and c is intercept of the line with the line. 
 
2.4. Displacement assay  
This was the final experiment to detect BaP. In this experiment the wells were coated 
with 6.0 μg/ml BSA-PHE (optimized concentration of coating conjugate) and blocked 
with Tris buffer (0.05M). The monoclonal mouse 4D5 antibody (0.0411μg/ml, 
optimized concentration) was exposed to the coating conjugate (without analyte). In 
parallel, a serial dilution of the BaP target was prepared (0.51ng/m to l10 μg/ml).  The 
addition of a specific concentration of BaP should bind to 4D5 antibody immobilized 
on the surface and carry it away (displace) from the well’s surface. The assay was 
conducted as described in section 2.3.3.8. The results from measurements with 
absorbance are shown in Figure 2.12. As it can be seen, the performance of the system 
showed a limit of detection of 0.0137ug/ml. In addition, the response showed a linear 
range between 0.37 to 0.0137ug/ml. It was possible to prepare the assay on the surface 

















Figure 2.12: Variation of absorbance with log of concentration of BaP 
 
2.4.10   Measurements of tap water  
A pre-treatment method was not required for the real sample measurements. A pre-
treatment method is a common practice in traditional techniques before measuring the 
samples. The analysis was carried out in a tap water sample. The tap water was taken 
from the LSI in Tyndall National Institute, Cork City. The Tris buffer 0.05M 
concentrations were prepared. The recovery of the spiked BaP in the tap water sample 
using AP label is illustrated in the Table 2.2 below.  
 
Table 2.2: Recovery study for Tap water sample with three different concentrations of BaP. ELISA 
format used was displacement assay 
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water 





The displacement assay was carried out. BaP was firstly diluted in DMSO. The 
blocking buffer used to prepare the serial dilutions was changed to tap water. The 
assays followed the steps as described in section 2.3.3.8. Absorbance was measured, 
after one-hour exposure to pAPP substrate, at 405 nm.  The recovery study was carried 
out to assess the applicability of the developed ELISA format in quantitative analysis 
of BaP in water.  Different concentrations of BaP diluted in blocking buffer (5 ng/ml, 
50 ng/ml, 100 ng/ml) were spiked in water sample. Analysis with the spiked water 
sample achieved unexpected results. It is observed that the higher the amount of BaP 
spiked in the samples; the less recovery was measured. The acceptable recovery 
percentage depends on the analyte concentration, if spike recovery fails to fall within 
the acceptance range, additional optimisation testing (such as changing the reagent 
diluent or assaying samples at a different dilution) may be necessary. 
 
2.5   Conclusion:  
In this chapter the development of an ELISA method for the detection of BaP 
compound was discussed. Capture and Displacement assays were developed for 
screening the BaP in a real water sample. Optimisation of different immunoassay 
regents and conditions were carried out for obtaining active assay performance.  
hapten-carrier coating conjugate was synthesised by coupling the interest hapten 
(phenanthrene-9-carboxaldehyde) with the carrier protein (bovine serum albumin). A 
Micro BCA Kit was used for quantification of total protein (BSA) and the 
concentration of the hapten (phenanthrene-9-carboxaldehyde) was determined using 
UV/VIS spectroscopy. Checkerboard titration assay was carried out to obtain the 
optimal concentration of the immunoreactants. The optimal concentration of the 




effective coating conjugate for the antibody response, a (MALDI-TOF MS) was used 
to characterize the coating conjugate resultant. MALDI-TOF MS was used to 
determine the PHEN-hapten density on BAS-carrier protein surface.  Optimisation of 
immunoassay incubation times was ensured. The optimization of immunoreactant 
binding time is one of the most important steps when developing ELISA assay. The 
result showed that the 60 min incubation time at 37oC was the optimal absorbance 
response under 1.0 at 405 nm. Depending on the instrument specifications and the 
UV/VIS manufacturer the dynamic range can vary. In our plate reader the best 
absorbance range values were from 0.2 to 1.5 units at the wavelength 405 nm and the 
values above 1.5 were excluded. Indirect displacement assay could detect the BaP 
analyte and the LOD was at 0.0137ug/ml in Tris buffer solution and the liner range 
was from 0.37 to 0.0137 ug/ml.  For the real sample measurements where no pre-
treatment methods were used, the analysis was carried out in a tap water sample. For 
the recovery study the tap water was spiked with known amounts of BaP. The result 
observed was that the higher concentration of BaP spiked in the water sample, the 
lower the value of recovery. Further study was performed using the same formats and 
buffers but using electrochemical cell consisting of three electrodes and 
electrochemical detection methods for screening and quantifying the concentration of 
BaP. This is discussed in Chapter 3.  
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Part 1: Screen-printed electrodes (SPEs) 

























3.1   Immunosensors 
Immunosensors are created through the integration of immunoassay methods in a transducer. 
As a compact analytical device, an immunosensor presents a surface where antigen-antibody 
complexes can be detected and also converted into electrical and biomechanical signals using 
transducers. The final detected signals can then be processed, recorded and displayed [1]. The 
advantages immunosensors in comparison to traditional PAH detection methods, such as Gas 
Chromatography–Mass Spectrometry (GC-MS) are several, including miniaturization of 
instrumental devices. They also need minimal reagents, small amount of buffer solutions, little 
use of organic solvents, and they do not require an extensive cleanup of samples due to 
potential contamination [2].  
 
 Also, immunosensors make it possible to analyse many samples at the same time, and permits 
in-situ analysis of environmental pollutants’ concentrations in a sample [3] [4]. This type 
allows for the fast screening of multiple samples. The detection of a positive presence of PAHs 
in samples would indicate the need for further analysis in the laboratory with more standard 
analytical techniques.   
 
As previously noted, immunosensors are a viable approach to the real-time and fast screening 
of PAHs [5]. Generally, they are grouped into three groups depending on the techniques of 


















An antibody can be used as a receptor and can be 
grouped according to the detection method [7,5], 
such as electrochemical impedance spectroscopy, 












The antibody-antigen complex triggers changes in 
the optical characteristics of the substrate, which 
can be detected by the use of different techniques, 
such as Total Internal Reflection Fluorescence 
(TIRF) and Polarisation-Modulation Infrared 
Reflection-Absorption Spectroscopy (PM-
IRRAS) [3]. Additional methods of detection 
include chemiluminescence, fluorescence [4], and 










The basis in of this type of transduction is the 
response of a surface to variations in the stress and 
loading applied to it. Velocity and position can be 
used in detecting measurement performance 
[1,13]. In addition, piezoelectric materials (where 
mechanical stress generates an accumulation of 
electric charge) such as quartz crystals have been 
used to immobilize antibodies and antigens [3, 9]. 
The linking of antibodies to these quartz crystal 
surfaces allows the immunosensors construction, 
which can directly determine the connection with 








The standardization of microfabrication techniques in the last 20 years has made the 
fabrication procedure for immunosensors simple. They allow for the possibility of using 
surface modification techniques to improve the orientation of the antibodies (Ab) immobilized 
on them (Figure 3.1), which makes the detection of PAHs in polluted water samples more 
effective. 
 Figure 3.1: Antibody orientations on immunosensors A) random immobilization B) oriented immobilization   
[14] 
 
Immunosensors are specific for a particular antigen that is capable of detecting a single target.  
However, for detection of different disease markers, such as cancers, the process of analysis 
is very complicated. This challenge has been addressed by the introduction of multiple arrays 
of sensors where each sensor can analyse a specific antigen. One instance of such an 
immunosensor has been reported where the electrodes were modified with anti-goat IgG, anti-
human IgG and anti-rat IgG. These electrodes were incubated with a mixture of three antigens 
and selective binding demonstrated [15]. Multiple analyses were also reported applying a flow 
injection instrument connected with four different electrodes in order to allow simultaneous 
measurements of four different samples for the detection of one analyte or by applying four 
separate electrodes, allowing detection of four targets in one sample [16]. Another report 




fetoprotein, carcinoembryonic, and carcinoma antigens. The screen-printed carbon arrays 
used to identify the antigens and the limit of detections were 1.1 μg L−1, 1.7 μg L−1, 1.2 IU L−1 
and 1.7 kIU L−1, respectively [17]. IU stands for International Unit and is specific effect when 
tested according to an internationally accepted biological process. Another group reported the 
design of gold electrode arrays which were embedded with antigens of five hepatitis variants 
namely hepatitis A to hepatitis E. Thus, the concentration of viral antigens could be detected 
[18]. 
 
3.2 Objective of electrochemical immunosensors  
3.2.1 Part 1: Screen-printed electrodes (SPEs)  
This section focuses on how the integration of immunoassay techniques in combination with 
electrochemical detection can provide a portable and very accurate solution for the detection 
of water pollutants that are detrimental for human health.  In particular, we focused our work 
on the quantification of polycyclic aromatic hydrocarbons in polluted water. Our integrative 
approach facilitates a faster detection of this family of organic compounds, by reducing the 
time of analysis. Additionally, the use of a lab-on-a-chip platform delivers a portable solution 
that could be used for in situ monitoring. Optimisation of a displacement assay, which 
investigates the presence and concentration of Benzo[a]pyrene (BaP) in water, allows the 
miniaturization of the standard ELISA format into a highly accurate system that provides fast 
results. The limits of detection obtained are comparable to those of state-of-the art tools, and 
achieve the values set by European Drinking Water Directive (0.01ng/ml, is the limit for 







3.2.1.1 Introduction  
Polycyclic aromatic hydrocarbons (PAHs) are a very large group of organic compounds made 
of carbon and hydrogen atoms. These compounds have an important impact on environmental 
pollutants. They are a primary concern for human health, as PAHs have been reported to 
increase the risk of cancer in humans [19-24]. It is therefore, very important to identify a 
method for detecting them in any matter that humans may get in contact with, such as food, 
soil and water. The European Drinking Water Directive (98/83/EC) recommends a value of 
0.01ng/ml as a limit for Benzo [a] pyrene (BaP) levels in drinking water [25]. Currently, 
detection of PAHs in the environment was done using commercial equipment, such as HPLC-
fluorescence detection and Gas Chromatography-Mass Spectrometry (GC-MS). However, 
these techniques are often expensive, use large amounts of toxic solvents, are time-consuming, 
and are not portable [26,27]. To address the shortcomings of these commercial techniques, 
this study presented an alternative electrochemical technique that can be used to detect PAHs 
within a short time; it is also portable, inexpensive, and environmentally friendly. 
Electrochemical immunosensors present great advantages in comparison to traditional PAH 
detection methods, in that they are easy to fabricate and use, without reducing their levels of 
detection or sensitivity.  This work shows how the integration of electrochemical techniques 
with an immunoassay method can reach limits of detection as low as required for the analysis 
of water samples in situ and in real time. In particular, we were able to detect the presence of 
Benzo [a] pyrene (BaP) in water. The development of this system is based on the use of   
Screen-Printed Electrodes (SPEs), which are integrated with the aforementioned methods 
(electrochemical techniques with an immunoassay). The SPE system contains a three-
electrode set that allows the combination of electrochemical measurements with immune-
sensing techniques. The best results obtained were achieved by adapting the protocol of an 




Our findings indicate that the adaptation of the immunoassay protocol reduces detection time 
to less than 3 hours. The ability of this system to reduce dramatically the performance time of 
a standard immunoassay (optical immunoassay) and the integration into a portable lab-on-a-
chip solution, could represent a future platform for the home-testing for water quality 
monitoring and avoid costly and inefficient analysis of water samples in dedicated 
laboratories.  
3.2.1.2 Experimental   
3.2.1.2.1 Materials 
For the synthesis of BSA-phenanthrene coating conjugate: the following were purchased from 
Sigma (Dublin, Ireland): bovine serum albumin (BSA), adipic acid dihydrazide (AAD), 
phosphate buffered saline (PBS), 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDAC), 
diethanolamine dimethyl sulfoxide (DMSO), phenanthrene-9-carboxaldehyde, sodium 
cyanoborohydride (NaCNBH4), and sodium hydroxide. Hydrochloric acid 37% was bought 
from KMG ULTRA CHEMICALS LTD (England). Slide-A-LyzerTM Dialysis Cassettes 
10K (0.5–3 mL) were purchased from Thermo Scientific and were used for purification of 
proteins. Monoclonal mouse antibody 4D5 specific to BaP was bought from Santa Cruz 
(Heidelberg, Germany). Sodium hydrogen carbonate, sodium chloride, detergent Tween-20, 
Tris salt, BaP, alkaline phosphatase (AP) labelled goat anti-mouse antibodies (whole 
molecule) were all purchased from Sigma (Dublin, Ireland). In order to ensure optical 
detection, a standard 96 well ELISA microplate was bought from Greiner bio-one (Germany). 
For the electrochemical sensor the substrate was para-aminophenyl phosphate (pAPP) salt, 
which was bought from Gold Biotechnology Inc., USA. Potassium chloride (KCl) and 
Diethanolamine (DEA) were bought from Sigma (Dublin, Ireland). All reagents were of 
analytical grade, and any water used in the solutions was nanopure water (having 18.2 




screen-printed electrodes (Kanichi 3 mm Graphite, KRS-1001) were provided by Kanichi 
Research Services Ltd (UK). 
3.2.1.2.2 Instrumentation 
A PalmSens potentiostat (Palm Instrument BV, the Netherlands) was used for the 
electrochemical measurements. For incubation, a Biometra OV3 Incubator (Gottingen, 
Germany) was set at 37 C. A Plasma Cleaner (45watts) (Harrick Plasma, Ithaca, New York) 
was used for removing organic molecules from the surface of SPEs. A Nitrogen spray gun 
was used to dry the SPEs between measurements. A UV absorbance reader for ELISA 
applications was provided by Thermo Fisher. A nanopure water system was bought from 
ELGA. 
3.2.1.2.3 Procedures  
• Preparation of phenanthrene–protein coating conjugate 
The preparation was completed as described in section 2.3.3.1.  
• Screen-printed electrodes (SPE) cleaning 
The SPEs needed to be cleaned with isopropanol before use, and then dried with a nitrogen 
gun. The SPEs were additionally treated in a plasma asher (45 watts) for 30 minutes, in order 
to remove any organic compounds. The SPEs were stored in dry and dark conditions for 
further application of immunoassay methods and electrochemical detection. The SPE used 
contained graphite working electrode (0.071cm2), graphite counter electrode and Ag/AgCl 








                            










   Figure 3.2: Kanichi Research Services Ltd screen-printed electrode  
 
• Capture assay: optimisation of monoclonal mouse 4D5 antibody specific to 
Benzo[a]pyrene (BaP)  
1 µl of coating conjugate (6.0 µg/ml) was added to the working electrode and allowed to bind 
for 30 minutes at 37 oC. The SPEs were washed with washing buffer three times and dried 
with the nitrogen spray gun. 4 µl of blocking solution was added to electrode, making sure 
that the working was completely covered and were left to incubate for 30 minutes at 37 oC. 
Then, the SPEs were washed again using washing buffer three times and were dried with a 
nitrogen spray. For the primary antibody step, a serial dilution of monoclonal mouse 4D5 
antibody in eight different concentrations was prepared. 2 µl of each concentration was placed 
to the SPE working area and allowed to bind for 30 minutes at 37 oC. Then, the SPEs were 




Finally, 2ul of AP labelled antibody was added and the SPEs were incubated for 30 minutes 
at 37 oC. The electrodes were ready to be measured using Lanier sweep voltammetry 
detection.    
• Michaelis – Menten Kinetics. 
 In AP kinetics, the concentration of the enzyme needs to be taken into consideration. The 
electrochemical detectable species (pAP) that is observed is the result of the hydrolysis of 
pAPP substrate (catalysed) by the AP enzyme, which is linked to the secondary antibody. The 
enzymatic reaction of the substrate (equation 1) involves the combination of a substrate (S) 
and the enzyme (E) to form a complex (ES).  This complex then breaks down into a product 
(P) and releases the enzyme (E). According to the Michaelis – Menten mechanism the 
enzyme-substrate complex takes place in first step of mechanism. Equation 1 shows the 
reaction of the single substrate [28]. 
                                           E+ S ↔ ES ↔ P + E                           (1) 
The rate ʋ of this reaction for a fixed enzyme can be explained as shown in (equation 2).   
                                              ʋ =       Vmax * [S]                                                  (2)                       
                                          Km + [S] 
Vmax is the maximum rate of the reaction (at saturated substrate concentration) and Km the 
Michaelis – Menten constant (corresponds to the substrate concentration determined as half 
of Vm ).  
• Displacement assay on SPE.  
In this assay, the target (analyte) displaces the primary antibodies (in our case 4D5 mAB) 
from the surface of SPEs. The amount of the antibodies left will attach to the secondary 
antibody, in our case the AP labelled anti-IgG. Optimised concentration values of the reagents 




primary antibodies that were bound to the surface through the coting conjugate. All washing 
steps were done with washing buffer 7.4 pH and were dried with a nitrogen spray. The 
prepared electrodes were connected to potentiostat in order to measure their individual 
response in a linear sweep voltammetry setting (parameters: Initial voltage = 0.2 V, final 
voltage = -1.6 V, scan rate 0.05 V/s, sample interval = 0.005V).  
 
3.2.1.3 Results and Discussion 
 
• Development of immunoassay protocol for SPEs 
The main aim of this work was to develop an electrochemical immunoassay using SPEs for 
the detection of Benzo[a]pyrene (BaP) in water. In this study, optimisation of different 
reagents was carried out on the electrodes in order to obtain the optimal concentration for a 
maximum antibody-antigen affinity. We chose a displacement assay form as it allowed us to 
reach low limits of detection and to obtain good assay sensitivity. This format is commonly 
used when the target is small and has only one epitope (the part of an antigen that is recognized 
by antibody). The optimisations of the main steps of the assay were carried out as follows: 
optimizations of concentrations of coating conjugate, optimisations of primary antibody 
concentrations, and optimizations of substrate concentrations. The following subsections will 
describe the results obtained in detail and link it to the final displacement assay used. 
• Optimisation of coating conjugate.  
The protocol was carried out as described in section 2.3.3.6.  
• Optimisation of monoclonal primary antibody  
The aim of this experiment was to optimize the concentration of monoclonal mouse 4D5 




This assay was developed by applying the coating conjugate (6.0 µg/ml) to the SPE working 
electrodes. The SPEs were blocked with 1% BSA in Tris 0.05M, pH 7.4 solution. A serial 
dilution of monoclonal mouse 4D5 antibody in eight different concentrations was prepared 
and applied to the working electrode of the SPEs. Cyclic voltammetry detection was used to 
study the reaction (Figure 3.3). Figure 3.3 illustrates the optimised concentration of 
monoclonal mouse 4D5 antibody before saturation level of the system. It was found that the 
optimal concentration was 0.37 µg/ml; this concentration was used in the final indirect 








Figure 3.3: (a) Example of a cyclic voltammetry plot obtained from the application of the capture assay. (b) 
Calibration curve obtained with the current peaks found for each concentration of the monoclonal mouse 4D5 
antibody. The control was without a primary antibody.  
 
• Optimisation of pAPP (Michaelis – Menten Kinetics)  
The enzyme kinetics for the pAPP substrate was studied at SPEs using amperometry method 
and the potential was applied 300mV in a stirred solution to determine the concentration of 
pAPP that would have a 95% of Imax. The measurement was set to 50 seconds. The 
biocomponents were applied onto the electrodes in a capture assay. Different concentration of 
pAPP were prepared [1mM-15mM]. The data were fitted by a non-linear regression based on 
the Michaelis – Menten model. The Km of pAPP 0.15915 mg/ml and the corresponding 






 Figure 3.4. Calibration curve of pAPP from amperometry readings in a stirred batch 
 
 
•   Displacement assay on SPE. 
This was the final experiment to detect BaP. In this experiment the SPEs were coated with 6.0 
µg/ml BSA-PHE (optimised concentration of coating conjugate) and blocked with Tris buffer 
(0.05M). As a next step, the monoclonal mouse 4D5 antibody (0.37 µg/ml, optimised 
concentration) was exposed to the coating conjugate (with yet no analyte). In parallel, a serial 
dilution of the BaP target was prepared (10 µg/ml to 0.01ng/ml). The addition of a specific 
concentration of BaP should bind to the 4D5 antibody immobilized on the surface and carry 
it way (displace) from the SPE surface.  The assay was conducted as described in section 
3.2.1.2.3. The results from measurements with linear sweep voltammetry are shown in Figure 




the calibration plot was constructed by plotting the current associated with peak at 0.60 V 











Figure 3.5.: (a) Linear sweep voltammogram obtained from the application of the displacement assay at 
concentration BaP of 0.166 ng/ml (b) Calibration curve obtained with the current peaks at a potential of 0.60 V 






As can be seen, the performance of the system shows a limit of detection of 0.07ng/ml. In 
addition, the response shows a linear range between 1 to 10 ng/ml.  It was possible to prepare 
the assay onto the surface of the electrodes in about 2 hours, and a single measurement with 
linear sweep voltammetry was done in 16s.  
3.2.1.4   Conclusion  
The work presented the development of an immunochemical method of detection for BaP. An 
SPE electrode was used as the surface where all the immunoreactions occurred. Optimization 
of the immunoassay was done by isolating the different reagents and studying the response of 
the system before saturation. The use of linear sweep voltammetry in combination with the 
immunoassay-SPE offered a low limit detection (0.07 ng/ml) for the screening of Benzo [a] 
pyrene (BaP). Linear sweep voltammetry detection with SPEs allows a simple system that 
could be used as a small portable method for in situ water quality monitoring. Although the 
LOD reached were very low, further study will investigate the increase in sensitivity of the 
system in order to reach the value set by the European Drinking Water Directive, (0.01 ng/ml, 
as the limit for Benzo [a] pyrene (BaP) in drinking water). Future work will integrate the 
already developed lab-on-a-chip platform, which will reduce the number of steps and the 
incubation time, due to the increase of surface-to-volume ratio. The use of such a platform 
will also make it possible to automat the steps that the immunoassay requires. Therefore, the 
integration into a portable lab-on-a-chip solution could represent a future platform for 
monitoring water quality and avoid costly and non-efficient analysis of water samples in 
dedicated laboratories.  
3.3 Objective of magneto-electrochemical immunoassay 
3.3.1 Part 2: Nanoparticles (NPs)  
To overcome the difficulties of commercial techniques, this work presents the integration of 




detect Benzo[a]pyrene (BaP) in water. Nanoparticles were used as a solid surface for the 
immobilization of antibodies, which were the main biomolecules of our immunoassay. The 
size of an antibody molecule is about 10 nm and nanoparticles of iron oxides are typically in 
the size range of 18-22 nm. Covalent binding has been developed. This method occurs through 
chemical processes, whereby the specific antibody with one of its functional groups (carboxyl) 
are linked to amine groups on the surface of the nanoparticles. This covalent immobilization 
method provides a strong bond between the antibodies and the nanoparticle, offering then a 
very reliable protocol for BaP detection. The limits of detection obtained (0.1ng/ml) are 
comparable to those of available state-of-the-art tools and close to the values requested by 
European Drinking Water Directive (0.01ng/ml). It also presents a linear range of (13.7 to 123 
ng/ml) that is practical in the detection of PAHs in water. The use of a magnetic platform 
offers the opportunity to integrate it into a portable solution that could be used for in situ 
monitoring of PAH in water. Having an in situ monitoring device is important for real-time 
and early detection of the potential presence of PAHs in water. This is a potential solution for 
domestic testing that would allow consumers to control the quality of their drinkable water. 
3.3.1.1 Introduction 
The work shows here presents the development of an electrochemical method to detect 
Benzo[a]pyrene (BaP), which aims to obtain a limit of detection at the values recommended 
by the European Drinking Water Directive (98/83/EC) (0.01ng/ml for BaP in drinking water 
[25]) The integration of an electrochemical method with an immunoassay principle can reach 
limits of detection [LOD] as low as required for the analysis of water samples in field and in 
real time. The development of this system is based upon the use of ferromagnetic particles 
(iron) that are integrated in the aforementioned methods. Ferromagnetic materials (iron-based 
materials that can form permanent magnets) have attracted research interest as a suitable 




multiple uses, have generated great expectations. The use of nanoparticle [NP] on this work 
offered advantages due to their unique size and physicochemical properties. This nanomaterial 
behaviour makes nanoparticles present unique optical, catalytic, magnetic, electrical, and 
chemical properties [33]. Also due to their unique characteristics, e.g., biocompatible, reliable 
orientation effects, good adsorption capacity, structural properties, and structural 
compatibility, new functional nanomaterial contains the ability to immobilize biomolecules, 
such as DNAS, antibodies, and enzymes [34]. These new functional nanomaterials have also 
been used to label biomolecules, promoting electron transfer, catalysing reactions, and 
enhancing the amplification of electrochemical signals [35-41].  As with many other scientific 
fields, electrochemistry has taken advantage of nanotechnology to produce sensors with an 
extra enhanced sensitivity, thanks specifically to the enhanced surface area to volume ratio 
that these particles offer. In our particular case, we were interested in the study of 
nanoparticles as carriers for the antibodies that were a key part of our immunoassay. 
 
 Ferromagnetic materials were therefore used here as a solid phase where biomolecules attach, 
with the potential to increase the number of biomolecules being immobilised on them [41-43]. 
This is due to the high surface to volume ratio that nanoparticles have. Ferromagnetic 
materials are also of interest as an elegant and easy solution for integration of the 
immunoassay in a lab-on-a-chip platform. The coupling of an immunoassay with an automatic 
microfluidic system would be ideal for screening BaP, in addition to providing a portable 
option. It would also reduce the time required to do the measurements. Due to the high surface 
area, heat transfer would be highly efficient, thus, reducing incubation times. In addition, 
magnetic and fluidic manipulation of nanoparticles reduces drastically the amount of washing 
steps. The results presented here were obtained by adapting the protocol of an indirect 




We will show that such adaptation of the immunoassay protocol on nanoparticles reduces the 
detection time. The ability of this system to reduce the experimental time of a standard 
immunoassay, and the potential for integration into a portable lab-on-a-chip solution could 
represent a future magnetic platform for the home-testing of water quality, thereby avoiding 
costly and inefficient analysis of water samples in dedicated laboratories. 
3.3.1.2 Experimental 
3.3.1.2.1 Materials  
The following materials were purchased from Sigma (Dublin):O-(2-Aminoethyl) 
polyethylene glycol [DAPEG], 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDC), 
phosphate buffered saline (PBS), sodium hydroxide, sodium hydrogen carbonate, sodium 
chloride, detergent Tween-20, Tris salt, BaP, alkaline phosphatase (AP) labelled goat anti-
mouse antibodies (whole molecule), magnetic iron oxide nanoparticles [Fe3O4], Ammonium 
hydroxide solution, Potassium chloride (KCl) and Diethanolamine (DEA). Hydrochloric acid 
37% was purchased from KMG ULTRA CHEMICALS LTD (England). Monoclonal mouse 
antibody 4D5 specific to BaP was purchased from Santa Cruz (Heidelberg, Germany). For the 
electrochemical detection, the substrate para-aminophenyl phosphate (pAPP) salt was 
purchased from Gold Biotechnology Inc., USA. All reagents were of analytical grade and any 
water used in the solutions was nanopure water (18.2 mΩ-cm). Disposable electrochemical 
screen-printed electrodes (Kanichi 3 mm Graphite, KRS-1001) were provided by Kanichi 
Research Services Ltd (UK). 
3.3.1.2.2   Instrumentations 
A CHI 1100 potentiostat (CH instruments, Inc. U.S.A) was used for the electrochemical 
measurements. For incubation, a Biometra OV3 Incubator (Gottingen, Germany) was set at 




A Plasma Cleaner (45 watts) (Harrick Plasma, Ithaca, New York) was used for removing 
organic molecules from the surface of SPEs. A Nitrogen spray gun was used to dry the SPEs 
in between measurements. For shaking at room temperature, a Heidolph ROTAMAX 
(Heidolph, Germany) was used at 120 rpm. 
3.3.1.2.3   Procedures  
• Preparation of PEG-ferromagnetic particles. 
In order to enhance traditional immunoassays, it was included iron oxide [Fe3O4] (magnetic 
particles) were included as a solid surface. In order to do that, the research focused on 
developing an appropriate linkage of the ferromagnetic particles with the antibodies used in 
the immunoassay. To target BaP, a connection between BaP-specific antibodies and the 
ferromagnetic beads was required. We prepared magnetic particles by covering them with an 
O-(2-Aminoethyl) PEG, and then covalently connected them to the antibodies by using 
protein immobilization techniques. O-(2-Aminoethyl) polyethylene glycol polyethylene 
glycol [PEG] (0.10 g) was dissolved in 4 ml of nanopure water under N2 purging with fast 
stirring. 2 ml of aqueous solution of magnetic iron oxide nanoparticles was then added 
(dropwise) to the O-(2-Aminoethyl) PEG solution. This solution was then made alkaline by 
the addition of 0.1 M ammonium hydroxide (4 ml) and left to react for 20 min at room 
temperature under the fume hood. Afterwards, the solution was centrifuged for a minute at 
12000 rpm and then collected by magnetic force. The resulting brown-coloured material was 
washed off with nanopure water, rendering Amino-terminated PEG-magnetic beads. 
• Capture assay: Optimisation of monoclonal mouse antibody 4D5 specific to BaP 
For the optimisation of the primary antibody concentration, which is used as a captor for the 
target BaP, a serial dilution of monoclonal mouse 4D5 antibody (0.2mg/ml) was carried out 
in 50 mM carbonate/bicarbonate buffer pH 9.5 (nine different concentrations were 




magnetite solutions. 0.2 mg of 1-ethyl-3-(3- dimethyl-aminopropryl) carbodi-imide (EDC) 
was then added. Linkers can create bonds between specific functional groups, since they are 
chemical species with very reactive groups at one or both ends.  The type of crosslinker 
(EDC) used in this work was a heterobifunctional crosslinker that has different reactive 
groups at both sides of the spacer arm. All the contents in the vial were left for 1 hour while 
















Figure 3.6: Schematic reaction of carboxyl-amine crosslinker. Carboxyl-amine crosslinker presents  
hetero-bifunctional chemistry (EDC). The carboxyl group of the antibody reacts with the amine on 
 the surface. 
 
After the last step of the capture assay, SPEs were connected individually to the 
electrochemical set up (potentiostat). Linear sweep voltammetry was used for the 




Diethanolamine (DEA, 0.1M) in the presence of KCl (0.1M) pH 9.5. All measurements were 
done by depositing a drop of the final solution on the working area of the electrode. The SPEs 
were cleaned beforehand with isopropanol and then dried with a nitrogen gun. The SPEs were 
additionally treated in a plasma cleaner device for 30 minutes, in order to remove any organic 
compounds left on their surface. The SPEs were stored in dry and dark conditions for later 
electrochemical measurements.  
• Displacement assay on ferromagnetic particles surface 
The displacement assay is a test where the analyte displays the antbody from the surface of 
the sensor. A serial dilution of BaP was prepared and was used to displace the primary 
antibodies that were bound to the surface. Optimised concentration values of the reagents were 
used for each particle's solution. All washing steps were done with washing buffer 7.4 pH 
.The prepared electrodes were connected to the potentiostat in order to measure their 
individual response in a linear sweep voltammetry setting (parameters: Initial voltage = 0.2 
V, final voltage = -1.6 V, scan rate 0.05 V/s, sample interval = 0.005V). 
 
3.3.1.3 Results and Discussion 
 
• Development of immunoassay protocol for ferromagnetic particles. 
The main aim of this work was to develop an electrochemical immunoassay using 
ferromagnetic particles for detecting Benzo[a]pyrene (BaP) in water. In this study, 
optimization of different reagents was performed in order to obtain the optimal concentration 
for a maximum antibody-antigen binding. Indirect displacement assay was performed in order 
to ensure good limits of detection and sensitivity. This format is common when the target is 






• Optimisation of monoclonal mouse 4D5 antibody specific to Benzo[a]pyrene (BaP). 
The objective of the experiment was to optimise the concentration of monoclonal mouse 4D5 
antibody on the ferromagnetic particles surface. This was done by using a capture format assay 
(the antigen to be detected is sandwiched between two antibodies). The diagram for capture 
assay is shown in Figure 3.7. Amino-terminated PEG-magnetite was used as a substrate to 
link them into the primary antibodies (as detailed in 3.3.1.2). Linear sweep voltammetry 
detection was used. The graph in Figure 3.8 shows the response of the SPE electrode in the 
presence of a solution with the amino-PEG nanoparticles and different concentrations of the 
4D5 antibody.  In Figure 3.8 (a) the peak noted at 0.60 V in the linear sweep voltammogram 
and in (b) the calibration plot was constructed by plotting the current associated with peak at 
0.60 V against the log of antibody concentration. The optimal concentration of monoclonal 
mouse 4D5 antibody is that which provides a maximum amplitude signal without reaching 
the system saturation level. In this case, as can be seen, the optimal concentration was 0.123 
μg/ml. This concentration was used in the final indirect displacement assay. 
Figure 3.7: Schematic of typical EI steps using magnetic beads [Fe3O4] as solid surface material for 
immobilisation of iimmunoreagents. The immunocomplex is composed of a capture antibody (Ab1) and a 
secondary antibody (Ab2) labelled with redox enzyme (E). The magnetic bead-capture ELISA conjugate is 
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Figure 3.8: (a) Linear sweep voltammogram obtained from the application of the capture assay at 
concentration antibody of 1.11 µg/ml. (b) Calibration plot for the monoclonal mouse 4D5 antibody using 
magneto-electrochemical immunoassay based on the current measured at the peak at 0.06 V in the linear 


































• Displacement assay on ferromagnetic particles 
This is the final experiment to detect BaP. In this study the ferromagnetic particles were coated 
with PEG polymer. The diagram for displacement assay is shown in Figure 3.9. Figure 3.10 
shows the linear sweep voltammogram for BaP concentration of 13.7 ng/ml and the calibration 
curve of the assay. The performance of the system showed a limit of detection of 0.5 ng/ml. 
In addition, the response showed a linear range from 13.7 to 123 ng/ml. A single measurement 













       
 









































Figure. 3.10: (a) Linear sweep voltammogram obtained from the application of the displacement assay at 
concentration BaP of 13.7 ng/ml (b) Calibration curve obtained with the current peaks at 0.60 V found linear 
sweep voltammogram for each concentration Benzo[a]pyrene (BaP) (range of concentrations from 0.01 ng/ml 
to 10 µg/ml) 































3.3.4    Conclusion  
In this work we have presented the development of an immunochemical method of detection 
for (BaP). [Fe3O4] particles were used as solid surface where all the immunoreactions 
occurred. Optimisation of the immunoassay was done by isolating the different reagents and 
studying the response of the system before saturation. This is a detail that will be beneficial 
for the long term goal of a portable solution for the on-the-spot measurement of BaP in 
drinkable water, as it will be possible to carry out all the steps in the immunoassay in the lab, 
with the exception of the final addition of the sample; this then can be left to the operator who 
is in the field and providing the required information about real time situation of the measured 
drinking source, such as a river. The use of linear sweep voltammetry in combination with the 
immunoassay- ferromagnetic particles offered a low limit of detection (0.5ng/ml) for the 
screening of Benzo[a]pyrene (BaP).   
 
The combination of linear sweep voltammetry detection with the particles provides a simple 
protocol that could be integrated in small portable systems. Although the limit of detection 
reached was not as low as we would have desired, further study will investigate the increase 
in sensitivity. One potential problem that may hinder the sensitivity was not having sufficient 
nanoparticles available to bind to our antibodies. This issue will be investigated by optimizing 
the concentration of magnetic nanoparticles. A second parameter that may be affecting our 
results is the orientation of the antibodies that are linked to the surface of the magnetic beads. 
It will be investigated by using alternative types of covalent immobilisation, such as direct 
chemistry (Periodate oxidation method) or introducing another kind of crosslinker 





Future work will integrate the already developed protocol based on magnetic nanoparticles 
into a lab-on-a-chip platform, which will help to reduce the number of steps and incubation 
time (this is due to the increase of surface-to-volume ratio). The use of such platforms will 
also make it possible to automat the steps that the immunoassay requires. Therefore, the 
integration into a portable lab-on-a-chip solution could represent a future platform for 
monitoring water quality and avoid costly and non-efficient analysis of water samples in 
dedicated laboratories. 
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Chapter 4  
Development and Characterisation 
of a lab on a chip electrochemical 











































































4.1. Aim and Novelty  
The main objective of this study was to develop an electrochemical immunoassay 
using microfluidic-integrated system (lab on a chip) for screening of PAHs in 
environmental monitoring of water. Development of an electrochemical cell-on 
chip configured in a three-electrode system and its characterisation for 
electrochemical application has been described. In this study, the chips were 
tested using PalmSens and contact angle instrument. The influence of different 
scan rates was studied in order to investigate the electrochemical process. The 
important aspect of the immunosensor is the method of immobilisation of 
antibodies to ensure the correct formation on the surface. Self Assembled 
Monolayer (SAM) was developed in order to achieve a specific attachment of 
antibody to study the SAM behaviour, Characterisation of monolayers on gold 
electrode has been carried out using CV, and contact angle measurements. CV 
was performed to determine the mechanism of electrochemical reactions on the 
SAM layer.  The goal of these electrochemical tests was to characterise the 
developed chip as a platform to be used in microfluidic-integrated system (lab 
on a chip). The alkaline phosphate (AP) enzyme used specifically converts the 
substrate (para –aminophenyl phosphate) (pAPP) into a measurable signal. The 
pAPP is dephosphorylated to form p- aminophenol (pAP) by reaction with 
enzyme, which was the oxidised at 0.300 mV to form the imino-quinone, thus 2 
electrons were generated (figure 4.1). The pAPP was chosen because of the 
product of pAP can be oxidised at mush less positive potential than the 
nitrophenol, an enzymatic product from nitrophenyl phosphate which would 
usually be used as an AP substrate for spectrophotometric detection.   
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Figure 4.1: Amperometric detection using an AP used as enzyme label. The substrate used was 
pAPP. At the potential applied (300 mV) pAPP undergoes 2 electrons oxidation to generate p- 
aminophenol (pAP) as a final product. 
 
4.2   Introduction  
Electronic technology allows for the miniaturization of a variety of devices. In order to 
achieve this goal, the microfluidic technology has to be integrated and must be able to 
analyse complex samples having various antigens. The label free techniques will 
become more significant in the near future. Inexpensive screen-printed electrodes will 
become more prevalent, which will permit the thorough screening of a large number of 
samples. The diagnosis of human health, quality control of food and water supplies will 
be easily monitored by a combination of electrochemical immunoassay methods, 
namely lateral flow assays, ELISA and enzymatic glucose biosensors.  Academic 
research indicates the presence of a variety of smart materials into the immunoassay 
system. [1-3]. The market for electrochemical immunoassays in the medical market in 
the U.S. has seen an annual increase of 6 % [4] Companies, such as Abbott Diagnostics, 
Beckman Coulter, bioMerieux, Roche Diagnostics and Siemens Healthcare are now 
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involved in manufacturing devices for oncology and endocrinology. It has been 
estimated that these devices will achieve a 75 % share by 2020, as a result of coupling 
the devices with cell phones and wireless technologies.  
4.3 Materials and Methods 
4.3.1 Reagents  
11-mercaptoundecanoic acid (11-MUA), EDC, NHS, Potassium ferricyanide/ 
ferrocyanide, acetone, 1-isopropyl alcohol, and ethanol were purchased from 
Sigma Aldrich (Dublin, Ireland).  Bovine serum albumin (BSA), 1-ethyl-3-(3- 
dimethylaminopropyl) carbodiimide (EDAC), Hydrochloric acid 37% were 
purchased from KMG ULTRA CHEMICALS LTD (England). Monoclonal 
mouse antibody 4D5 was bought from Santa Cruz (Heidelberg, Germany). 
Sodium hydrogen carbonate, sodium chloride, detergent Tween-20, Tris salt, 
BaP, alkaline phosphatase (AP), and labelled goat anti-mouse antibodies (whole 
molecules), all were bought from Sigma (Dublin, Ireland). For the 
electrochemical tests the substrate was para-aminophenyl phosphate (pAPP) salt, 
which was bought from Gold Biotechnology Inc., (USA). Potassium chloride 
(KCl) and Diethanolamine (DEA) were bought from Sigma (Dublin, Ireland). 
All reagents were of analytical grade or better, and any water used in the solutions 
was nanopure water. 
4.3.2 Instrumentations 
A PalmSens potentiostat (Palm Instrument BV, the Netherlands) was used for 
the electrochemical measurements. For incubation, a Biometra OV3 Incubator 
(Gottingen, Germany) was set at 37 oC. A Plasma Cleaner (45watts). (Harrick 
Plasma, Ithaca, New York) was used for removing organic molecules from the 
surface of the chip. 
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 A Nitrogen spray gun was used to dry the chip between measurements. A 
nanopure water system was bought from ELGA. 
4.3.3   The fabrication of the biochip 
The immunosensor consisted of an electrochemical cell- on- chip It was a three-
electrode system (gold as working and counter electrode and Ag/AgCl reference 
electrodes). The chip was configured in a multi-electrode array screening for real 
time environmental measurements. An electrochemical immunosensor array was 
for the simultaneous detection of PAHs. Design and fabrication of this electrode 
as shown in Figure 4.2 was performed in the Tyndall National Institute. Each 
individual electrochemical cell has working electrode (1.822 mm2), counter 
electrode (3.280 mm2) and reference electrode (2.18 mm2). The overall chip size 
is (6.733 mm x 24.7 mm).  











                        
 












4.3.4 Characterisation and preparation of the gold chip  
Electrochemical characterisation measurements were carried out with a 
PalmSens portable potenionstat. In order to connect the chip to the PalmSens, the 
interface for three-electrode system, which acts as a connector, was designed (see 
Figure 4.3). The PalmSens was connected to a laptop computer for conducting 
tests in the laboratory.   
 
Figure 4.3:  Electrochemical sensing array, with interface for connection to PalmSens detector 
and reservoir device for sample addition.  
 
The gold chips were tested using cyclic voltammetry (CV). CV detects the redox 
behaviour of species within a potential range. CV measurements were performed 
in the presence of 5 mM ferri/ferrocyanide in 0.1M KCL at a scan rate of 50 
mV/s between the applied potential ranges of-0.2 to 0.8 V.  
4.3.4.1  Studies on the influence of scan rate  
In order to study the effect of the scan rate, the chip was characterised between -
0.2 to 0.8 V in the aqueous electrolyte of ferri/ferrocyanide with the presence of 
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0.1M KCL. The CV measurements were performed in various scan rates from 5 
to 200 mV/s at room temperature (25 °C).  
4.3.4.2  Gold chip cleaning protocols  
In order to ensure that the gold chip surfaces were clean for electrochemical tests, the 
three-electrode systems were optimized with two cleaning protocols. The two cleaning 
protocols were ultrasonicating and plasma treatment.  After this, the chips were cycled 
three times in the aqueous electrolyte of ferri/ferrocyanide with the presence of 0.1M 
KCL at a scan rate of 50 mV/s. The potential was selected between a range of -.0.2 and 
0.8 V.  
• Ultrasonicating: The gold chips were cleaned firstly in acetone and then in 1-
isopropyl alcohol and lastly in deionised water. Each clean took 5 minutes.  
• The gold chips were cleaned in Plasma Cleaner for 20 minutes (45 watts). 
 













    
Gold chip (Au) 
Plasma cleaning surface 
Immersed in 5 mM 11-MUA (SAMs) 
solution for 20 hours and rinsed with 
absolute ethanol to remove unbound 
molecules and dried with N2 
Immersed in coupling agent 5mM 
EDC&NHS for 1 hour and rinsed 




4D5 monoclonal antibody 










4.3.4.4   Contact angle measurements    
 
Drop contact angle tests were performed in order to measure the surface hydrophobicity 
of the SAM surface. To form the droplet, the deionised water was pumped out of a 
syringe system at medium rate, namely 1 μl / s. 1 μl drop of water was placed on the 
surface. Tests were repeated for 3 drops on each chip (n=3).   
4.3.4.5   Amperometric detection  
Amperometric measurement with PalmSens allows for a simple device, which could 
be used as a portable solution for in situ measurement. The measurement was set to 60 
seconds pAPP ds and the potential was applied at 0.3 V versus Ag/AgCl. The current 
was measured and was allowed to reach the stable baseline. The final concentration of 
the pAPP in the buffer was 3mM. The pAPP solution was freshly made up and stored 
in a dark area, as it was sensitive to light. 
4.4 Lab on a chip design  
For the design of the fluidic interface, a fluidic cartridge was fabricated by the injection 
moulding. Injection moulding is a method of making plastic parts by melting the plastic 
substance and injecting this into an injection mould tool. This can be seen in Figure 4.4. 
Its main functions were to hold the fluids under analysis and to cover the whole surface 
of the gold chip. The fluid was driven via a set of valves and a portable pump, which 
were controlled by the electronic module .Figure 4.5 showing the fluidic channels 
across the chip and the portable pump and the valve control tab. Figure 4.6 shows an 





























Figure 4.5: The fluid channels across the chip , fluidic cell with electrode chip electronics, portable pump 
and valve control Tab. 
Figure 4.6: Images of a euro coin to help clarify dimensions of the setup and the microfludic cell with 
the chip.  
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The electronic module unit was responsible for fluidic control (Figure 4.7). 
Amperometric electrochemical detection was embedded in a microfluidic device, 
which could be used to detect the presence of an electrochemically active species in the 
sample under study. 
 




4.5 Smarter-SI Q-Sense (Measurement GUI)  
In the Q-Sense cell when the potential was applied to the system, electrostatic 
force was generated that could be made to cause liquid flows to move, merge, 
mix, spilt, and dispense from valves. The operation of the integrated system was 
achieved using Q-Sense GUI. The device was designed with a specific 
application. Figures [4.8- 4.12] show the images for the GUI of Q-Sense. 
4.5.1. Raspian Desktop  
Figure 4.8: Q-sense system desktop  
 
4.5.2. GUI – Tabs  
Figure 4.9:  Q-sense system Tabs  
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4.5.3. GUI – Pump and Valve Control Tab 
 
Figure 4.10:  Q-sense system pump and valve control Tab  
 




















4.5.5. GUI – App Control Tab 
 
   Figure 4.12:  Q-sense system App control Tab  
 
Simulations were also carried out to guarantee flow in the system. The software 
was called COMSOL (Figure 4.13). The simulation was liquid flow as it came 
in from the inlet and left at the outlet. It basically tells us the distribution of liquid 
in the chamber. Blue colour for higher quantity and lighter colour for less. These 
simulations provided an insight into how the liquid flow spreads in the area of 
the microfluidic capsule. Visualisation of the flow ensures the avoidance of dead 
areas that would not be covered by liquid. As can be seen in Figure 4.10, the 
liquid is expected to spread evenly in the space given by the microfluidic capsule. 
Velocity profile in microfluidic channels helps to understand how the fluid 
behaves while it is transported through the system and the nature of the fluid and 
direction of the fluid particles.  Velocity profile shows the difference in intensity 
of resistance of fluid particles across the flow, due to cohesive and adhesive 
forces. The blue-to-red rainbow represents the flow-velocity magnitude 





Figure 4.13: Simulations of liquid flow from inlet to outlet at microfluidic capsule (pressure 
driven flow). 
 
4.6 Results and discussions  
4.6.1 Characterisation of the gold chip  
4.6.1.1 Influence of scan rate  
The effect of the scan rate was investigated using the CVs over the range of 5 to 200 
mV/s for the ferrocyanide redox probe. As shown in Figure 4.12, large peak separation 
was observed by increasing the scan rate.  The effect of increasing the scan rate resulted 
in the higher current. The current was found to be directly proportional to the square 
root of the scan rate indicating diffusion limited process, which is governed by the 
Randles–Sevcik equation 
                                          ip = (2.69 × 10-5) n3/2 AD1/2Cv1/2           Equation (1) 
where ip is the peak current, A is the area of the working electrode, C is the 
concentration of the electroactive species at the electrode, D is the diffusion coefficient 
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of the electroactive species,  is the scan rate, and n is the number of electrons in the 
redox reaction. A good linear correlation was obtained between the anodic peak height 
and the square root of the applied scan rates, as shown in Figure 4.14.  
 
Figure 4.14: Influence of the square root of scan rates of 5 mM ferri/ferrocyanide at a bare chip. 
Supporting electrolyte was 0.1 M KCL   
  
The table below indicates CV data for the oxidation of 5 mM ferri/ferrocyanide in 
0.1 M KCL with different scan rates. CV tests were carried out at room temperature 
(25°C). A shift in anodic peak potential with increasing scan rate indicates a   quasi-






Table 4.1: Influence of scan rate on the peak potential for 5 Mm ferrocyanide. The scan rate were  
5 mV/s, 10 mV/s, 20 mV/s, 50 mV/s, 100 mV/s, 150 mV/s and 200 mV/s. 
 
a Measured from the value ½ (Epc +Epa) versus versus Ag/AgCl reference electrode 
 
b 
∆Ep = (Epc-Epa)  
c Ep anodic data here as a function of scan rate 
 
4.6.1.2   Influence of chip cleaning protocols  
Cleaning and substrate preparation were important steps in order to study the surface 
phenomenon as they can improve the surface state for better electrochemical activates 
to take place. In this research, we employed two different established protocols to clean 
the chip for electrode regeneration. Chip cleanliness can be measured by looking at the 
potential differences between peak-to-peak separation of anodic and cathodic peaks. 
Figure 4.15 illustrates the CVs after treating the chips using all the considered cleaning 
protocols, as already described in section 4.3.4.2. Considering the theoretical value of 
∆Ep is 59 mV for single electron transfer of   ferri/ferrocyanide redox couple, the closest 
experimental value of ∆Ep (58 mV) was achieved when the CV was performed using 











5 122 228 230 
10 132 256 260 
20 161 318 320 
50 210 340 350 
100 239 282 380 
150 285 290 430 
200 296 288 440 
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the chip treated with the plasma asher (45 watts). Plasma cleaning involves the removal 
of contamination from the surface through the use of energetic plasma created from 
oxygen gas species. Compared to other cleaning protocols, plasma-cleaning method 
shows well-defined peak. For this reason, we constantly used this method as our 














Figure 4.15: Studies on different chip cleaning protocols. CV was scanned in 5 mM 
ferri/ferrocyanide redox couple with a 50 mV/s scan rate.  
 
4.6.1.3      Gold chip arrays modification procedure (Self Assembled 
Monolayers (SAM)) 
A self-assembly of 11-MUA was used to modify the gold chip in order to control 
the orientation of the biomolecules (Abs) binding to the surface. The approach 
performed involved the modification of the gold chip using carboxylic acid 
terminated SAMs. The chemisorption of thiol and disulfides on gold chips has 























become one of the most common applications of SAMs. CV measurements in 
Figure 4.16 show a decrease of ferri/ferrocyanide anodic and cathodic peak 
current after the immobilisation of 11-MUA SAM on the chip surface. This 
situation is caused by the reduced mass transport of highly ordered monolayers 
which blocked the probe molecules, thus preventing them to penetrate through 
the well-packed layer. Low current was observed for the 11-MUA SAM 
immobilised gold electrode, evidencing surface saturation and suggesting that a 
monolayer of fixed molecules was achieved. The addition of EDC/NHS to the 
carboxylic acid terminated SAMs increased the coverage of the antibodies. The 
primary monoclonal antibody was performed 30 minutes a 37 oC after the 
activation of EDC/NHS. As shown in CV, after the introduction of protein, the 














Figure 4.16: CVs of (i) bare Au: (ii) 20 hours 11-MUA SAM (iii) activation with EDC/NHS 
and (iv) immobilisation of primary monoclonal antibody. Electrolyte used was 5 mM 
ferri/ferrocyanide redox couple in 0.1M KCL with a 0.05 V /s scan rate.  


























4.6.1.4.    Contact angle measurements    
 
The structural information and surface chemistry test of the modified gold 
surface was determined by using drop contact angle. Upon comparing the 
modified gold chip with a bare gold chip, it was found that the modification of 
the gold surface influenced the water contact angle. The bare gold chip had a 
contact angle of 55.07 degree. The modified gold chip had a contact angle of 
35.58 degree. The contact angle of the modified gold chip had a lower value due 
to the SAM formation. The low contact angle revealed a hydrophilic surface of 
the carboxylic acid monolayer that consisted of the tail groups of the thiols. The 
tail groups of the thiols had a less hydrophobic surface. Figure 4.17 indicates the 
measurements of contact angle before and after the SAMs formations. 
 
Figure 4.17: The contact angle tests before and after modification of the gold chip with 11-MUA 
SAM 
 
4.6.1.5   Amperometric detection  
Amperometric measurements were performed using the PalmSens potentiostat. A 
sensing chip with small working electrode improves the signal to noise ratio and the 
lowers the limit of detection in low concentration. Before the measurements, the chip 
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coated with layers of biocomponents assay was stored in DEA buffer pH 9.5 at 4 OC to 
prevent the loss of antibody activity. The detection was conducted on the coated chip 
using the AP enzyme and the pAPP substrate. Before carrying out the amperometric 
detection, the chip was rinsed with nanopure water and dried with nitrogen gun.  A 
volume of 10 ml substrate solution was prepared. The chip was immersed into it and 
the chip active area was covered by the solution.  The solution was stirred using a small 
magnetic bar. The measurement was 60 seconds and the potential was applied at 300 
mV. The current was monitored and was allowed to remain the stable baseline (see the 
Figure 4.18). At 10 seconds, a 200 µl of pAPP (final concentration of 3mM) was 
injected into the buffer of the gold chip. The increase of current was recorded as the 
signal for data evaluation. Upon pAPP injection, the increase of current was recorded 
as the signal for data evaluation.  
 
Figure 4.18: Typical signal for amperometric detection. The chip modified AP consisting   bilayer 
(immunoassay format) was measured in DEA solution pH 9.5 at a potential of 300 mV. The 
substrate pAPP was injected at 10 seconds 




























4.7 Development of an integrated sensing system (Lab On a Chip)  
4.7.1.  Proof of concept  
In order to determine if the developed microfluidic system was compatible with 
electrochemical measurements, analysis tests were performed. This was to 
ensure that the system could hold and deliver the sample, and that the 
electrochemical chip connection worked correctly. The resulting graph, seen in 
Figure 4.19 shows the unmodified chip results when the chip was not coated with 
layers of biocomponents assay or any applied method.  
The characterisation was investigated by performing the electrochemical 
detection. The resulting graph shows also that the connections of the system 
















Figure 4.19: Electrochemical detection at bare chip. Electrolyte used was 5 mM 





The graph seen in Figure 4.20 shows the coated chip results. The detection was 
carried out on the coated chip using the AP enzyme and the pAPP substrate.  
Amperometric detection allowed simple device and integration of the sensor in 
a portable system for real-time and inexpensive measurement in the field [6]. 
SAMs formation was developed on a chip surface in order to achieve a specific 
immobilization of capture antibody. The capture antibody used was monoclonal 
mouse antibody 4D5. The enzyme AP was used in combination with pAPP 
substrate for detection. Capture ELISA format was used to ensure the correct 
formation on the chip surface. The amperometric result shows that the 















Figure 4.20: The amperometric tests with typical signal of Q-sense. The gold chip array modified AP 
consisting bilayer (immunoassay format) was measured in DEA solution.  
 
























Q-sense signal for amperometric detection with modified gold chip.
The substrate pAPP injection and control were measured in DEA 





Before carrying out the amperometric test, the chip was left over night in the DEA 
solution in order to maintain the activity of the antibodies. The finding showed a 
read-out obtained from the Q-sense system. The results indicated that there was a 
clear peak for the immunoassay components.  At 54 seconds, pAPP solution (final 
concentration of 3 mM) was delivered to the cartridge chip via the substrate valve, 
which was controlled by the electronic module. The increase of current was recorded 
as a signal for data evaluation. The sample with immunoassay yielded much higher 
positive current from amperometric measurements due to the AP concentration in 
the solution. It also appears on this plot that the current for immunoassay sample 
was decreasing exponentially whereas the control was almost linear. The overall aim 
of this section of research was to integrate the microfluidic design with a 
heterogeneous immunoassay and electrochemical methods to detect PAHs in water 
sample. The design of the system also allows for electrochemical chips to be inserted 
and removed easily. This shows the potential for inserting many other chips into the 
system, for the electrochemical analysis of a variety of parameters. The preliminary 
result for the above measurement is a proof of concept that the system works, both 
from an engineering and analytical chemistry perspective. Due to delays with the 
manufacture of the Q-sense system as proof of concept established. Future work will 
focus on the implementation of the device. The data representative of electro-
analytical response of the Q-sense system for these immunoreactions, obtained us a 
useful starting point for development of the fully integrated system. Future work will 
also optimise different immunoassay parameters in order to achieve better assay 
performance. The next step then is to conduct on-site testing of the system in water. 
This can be carried out at any stage in the near future as the system is ready for use. 
From this, the device will be optimised for best fit into the production process.  
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4.7.2   Troubleshooting and future work  
•    Make the system and the chip more compact and integrated.  
•    Improve the battery performance and the software reliability. 
•    Integrate wireless connection in order to share data. 
•   Consider designing a tool/accessories box for the on-site tasks  
  It is necessary to redesign and refabricate the Pyrex 7740 glass substrate (Figure 4.21). 
The refabricated glass chip will be used for PAHs screening using an immunoassay 
format. PAHs are very nonpolar and lipophilic, and therefore can easily stick to plastics. 
This forces researchers to use glass for sampling and storage. For example, in collecting 
PAH samples for laboratory analysis, researchers noted that plastic materials should 
not be used for storage and sampling due to “the possible adsorption of the PAHs onto 
the plastic container material” [7]. The refabricated glass chip must be a three-electrode 
system consists of gold as working, platinum as counter electrode and an Ag/AgCl 
reference electrode. When applied them to electro-analysis, these materials are stable 
over the course of many measurements, and can be used several weeks after preparation 
with no loss of signal. Therefore, the new glass substrate should be thicker in order to 
avoid the breakage of glass when entering to the Q-sense system.  In addition, the pads 




 Figure 4.21: The Pyrex glass substrate, Example of Q-Sens immunosensor in H2020 project 
SMARTER-Si. This immunosensor is being used for water quality monitoring. 
 
4.8 Conclusion  
This chapter explained the development of a chip containing a three-electrode 
system and its characterisation in an electrochemical application. PalmSens 
portable potentiostat and contact angle device were used for the characterisations 
of the chips. Electrochemical behaviour of the chip was investigated using a 
redox probe in the presence of 0.10 M KCL. This redox probe is one of the most 
studied complexes in electrochemistry. The redox pair (ferri/ferrocyanide) was 
used to characterise electrochemical systems. CV was carried out in order to 
study the mechanism of the electrochemical reactions. Investigation of the 
influence of the scan rate was performed in order to study the electrochemical 
processes, in which the optimised scan rate was observed at 50 mV/s. The 
important factor in an immunoassay was to immobilise the desired antibody on 
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specific targeted sites with no non-specific binding. SAM formation was used in 
order to decrease random orientation of the antibodies binding to the surface. 
Modifications of SAM on the gold chip surface with (11-MUA) were performed. 
Activation of carboxylic acid-group with EDC in combination with NHS was 
used to the monolayer before the immobilisation of antibody. Characterisation of 
the SAM formation on gold surface was carried out using CV and contact angle 
tests. The SAM-modified chip surface was less accessible to redox pair. The chip 
surface became more insulated after the addition of modification layers. Contact 
angle test was performed to study the hydrophilic surface.   
 
The end groups of thiol in SAM formation influenced the drop contact angle of 
coated SAM gold chip.  Amperometric detection using the Q-sense system was 
developed.  The system was based on detecting the specific antigen using an 
enzymatic reaction by measuring the chemical response to specific antibody. 
Amperometric detection with the microfluidic cell allows a simple tool that could 
be used as portable system for field measurements.   The use of immunoassay 
method is viable for screening of PAHs. This technique allows for detecting 
multiple samples and analysis can be completed reasonably quickly.  While the 
integrated system has proved successful in a lab-based setting, as the end aim of 
the research is to use this system in water environment, it will be brought into the 
water environment to carry out tests with their existing process. In this way, any 





The summary of evolution of Q-sense design and fabrication chip was outlined 
in the list above. In this way, any issues that may arise from environmental setting 
can be rectified in an efficient manner. The summary of evolution of Q-sense 
design and fabrication chip was outlined in the list above. 
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Chapter 5  






























5.1   Comparative Study  
A comparative study using analytical chromatographic–based approach was 
performed in order to ensure that the already developed immunoassay sensor 
system met the requirements of the analytical methods for laboratory tests.  The 
comparison was carried out to confirm that the procedure applied for a PAH test 
was suitable for its intended use. It was also conducted in order to compare the 
reliability and sensitivity of the developed immunoassay results. It was an 
important study of good analytical practice. The presence of PAHs has been 
detected by using Gas Chromatography-Mass Spectrometry (GC-MS). In 
particular, the work focused on the quantification of Benzo[a]pyrene (BaP). This 
study was performed in the Analytical Laboratory in the School of Chemistry at 













5.2   Introduction 
5.2.1   Conventional PAHs Analysis Methods 
PAHs occur in different forms and concentrations in environmental areas, such 
as water, air, and soil. Consequently, this leads to the need for the application of 
different methods of analysis depending on each particular case [1]. Currently, 
the common traditional analytical methods used to detect PAHs include high-
performance liquid chromatography (HPLC) with fluorescence detection, Gas 
Chromatography-Mass Spectrometry (GC-MS), and high-performance liquid 
chromatography with ultraviolet detection (HLPC–UV) [2]. There are several 
advantages that are associated with the use of these standard analysis techniques, 
such as accuracy, reliability and sensitivity.  
However, there are limitations associated with these methods. Some of these 
disadvantages include the fact that their processes involve high-risk loss of 
analytes during sample separation. In addition, these methods require the use of 
an extensive amount of hazardous organic solvents [3]. This is a problem because 
it increases costs and contaminates the environment. Loss of analytes presents a 
major source of poor quality analytical data for PAH due to separation, pre-
treatment, and sampling of analytes, which introduce errors that are not 
associated with the last quantification step. In addition, the application of these 
methods makes the procedure of sample analysis, preparation, and quantification 







5.2.2   Environmental monitoring study (Drinking Water) 
According to the World Health Organization (WHO), the PAHs with the highest 
concentrations in drinking water are anthracene, pyrene, phenanthrene, fluoranthene. 
These are measured in surface water for regulatory purposes because of their low 
solubility and high affinity for particular matter. Fluoranthene compound, in particular, 
is measured to a significant extent. Some PAHs compounds are toxic and considered 
as mutagenic, carcinogenic and teratogenic substance, e.g., Benzo[a]pyrene (BaP). BaP 
is the compound that has been studied and it has been identified as a hazardous 
environmental pollutant. The table outlines the physicochemical properties of BaP [5].  
Table 5.1: physicochemical properties of BaP. 
  
 Benzo[a]pyrene 




















C20H12 5 178.1 496 7.3x10
-10 3.8 
 
In aqueous areas under aerobic conditions, PAH slowly biodegrades. In addition 
biodegradation occurs in accordance with increased number of aromatic rings.                      
In one research study [6] the volatility of BaP in water was found to be low and the 
calculated half-lives for the selected analytes varied widely (from 500 to 1550 hours).                        
The key process for PAH degradation in water is indirect photolysis under the influence 
of hydroxyl radicals. In another study a reaction of PAH and hydroxyl radicals showed 






5.2.3   Study with coal tar  
In the past a common coating item used for distribution water pipes was coal tar. It was 
used for effective protection against corrosion. Coal tar is a mixture of 1000 compounds 
and 30 compounds of the mixture are PAHs [10]. According to the (WHO) it is clear 
from some reports in the recent literature that this practice was discontinued [5]. 
However, many countries still have a huge number of distribution pipes lined with coal 
tar. Coal tar coating is the main contamination source of drinking water with PAHs. 
Environmental levels of PAHs have been recorded in water after following repair work 
and the passage of water through distribution pipes [11]. The relative amount of PAHs 
in water relies on the solubility and the chemical profile of them. The effect of complex 
PAHs is different from that of individual PAHs. The interaction of PAHs in coal tar 
and in other materials may bring about higher or lower rates of tumor than can be 
obtained from their content of carcinogenic PAHs [12, 13]. A study based on the oral 
carcinogenicity experiment revealed that the guideline value for carcinogenic BaP in 
drinking water association with coal tar coating was estimated 0.7 ug/ L [14]. In order 
to support the validity of the previous study, another experiment was carried out, which 
yielded near similar results. [13, 15]. The presence of BaP in drinking water at notable 
amounts is a sign of the presence of deterioration of coal tar linings.  In light of Irish 
research which shows that PAHs originate from many sources including coal-tar 
coating of drinking water pipes, soot, vehicle emissions and as combustion products of 
hydrocarbon fuels [16]. The recommendation of the (WHO) is that the use of coal tar 
linings and storage tanks to be discontinued and replaced by new ones. The WHO has 
also recommended that the levels of PAHs in individuals be monitored, along with its 




5.3   Objective  
The aim of this chapter is to compare the developed immunoassay system discussed in 
the previous chapters for the detecting of Benzo[a]pyrene (BaP) in drinking water. The 
European Union (EU) has produced a list of a series of (PAHs) found in the 
environmental that require monitoring. The determination and quantification of low 
concentration of PAHs have been extensively performed with chromatographic 
methods over the past decades. Here, a method based on Gas Chromatography-Mass 
Spectrometry (GC-MS) has been used. GC-MS is able to enter the volatile compound 
and into, the column rapidly and in as small a volume as possible. Standard and real 
sample tap water analyses were carried out targeting PAHs compounds that obtained a 
good sensitivity at UCC, Cork City. Analysis of a tap water sample with optical 
detections was also carried out.  
5.3.1   Experimental: 
5.3.1.1 Standards and reagents: A PAH calibration mix containing 15 monitored 
compounds was obtained from Sigma (Dublin, Ireland). The working PAH mix was 
diluted separately in acetonitrile solvent with a final concentration of 7 µg/ml using 
glassware and pipets. The determination of the quantitative analysis was carried out   a 
5 point calibration curve. The concentrations of the standards were 3, 4, 5, 6 and 7 µg 
/ml (ppm). All samples were run in triplicate (n=3).  Reagecon (PAH) Internal Standard 
(6 Compound Mix) in Dichloromethane was commercially obtained from Reagecon 
Diagnostics Ltd. (Shannon, Ireland). International standards solution was used in order 
to obtain the required response of the instrument for analytes and to identify the 




extraction disks 2215 with 47 mm in size was purchased from Supelco (Dublin). All 
reagents and solvents used were of analytical grade or better.  
5.3.1.2   GC-MS conditions and instrumentation:  
The study was performed on Agilent 6890/5973 gas chromatography-mass 
Spectrometry (GC-MS). Analysis of samples was performed on an Agilent 6890N GC 
equipped with a 5973 inert Mass Selective Detector. A capillary column HP-5MS [ 
(5%-phenyl)-methylpolysiloxane] Agilent J & W GC column, 30 m, 0.25 mm i.d., 
coating thickness 0.25 μm was used to separate analytes.  Each sample was placed on 
an auto-sampler (Agilent) and injected in a volume of 5 μl into the GC/MS with the 
splitless mode of injection. The GC/MS method consisted of a front inlet temperature 
of 280 °C, MS transfer line temperature of 280 °C, and the ion source temperature was 
250 °C, and ionization voltage 70eV. The solvent delay was 4 min. The flow rate of 
helium through the column was kept at 1.0 mL·min−1. The oven temperature was 
ramped as described in the Table 5.2. 
Table 5.2: Agilent 6890/5973 gas chromatography-mass Spectrometry conditions 
GC run conditions  MS conditions 
Analytical 
column 
A 30.0 m, 0.25 mm i.d. HP-5MS 
capillary column with 5% phenyl-













Injection mode Splitless mode of injection used 
to maximize sensitivity 
 Tune Etune.u 
Injection 
temperature 
250 oC  Gain factor 1 
The carrier gas Helium, constant flow mode, 1.0 










60 oC for 1 min raised to 120 oC at 
the rate of 25 oC/min, then to 160 
oC at the rate of 10 oC/min and to 
280 oC at the rate of 5 oC/min, held 





Figure 5.1:  Agilent 6890/5973 gas chromatography-mass Spectrometry (GC-MS) instrument. 
 
Water should be eliminated from compounds before injection into the GC-MS because 
they could impact on GC column lifetime, inlets and detectors. Filtration is the most 
common method for removing water from the sample. 
5.3.1.3   Water extraction  
The water sample was filtered using fiberglass filtration in order to remove any solids 
that might prevent the extraction procedure. For this procedure fiberglass filter paper 






5.3.1.4   Disks preparation 
The disk had to be conditioned before using it in the extraction process. A solid phase 
extraction disk (SPED) was conditioned by inserting it into the 47 mm apparatus for 
filtering as shown in Figure 5.2. According to US Method 525.2 for GC-MS ethyl 
acetate (5ml) was used to soak the disk for 1 min. This is followed by vacuum drying 
of the disk. Ethyl acetate is a slight polar aprotic solvent that is immiscible with water 
and able to dissolve the organic compounds. This was followed by soaking the disk in 
methanol (5 ml) for 1 min. The disk was removed from the methanol in such a way that 
a layer of methanol was retained on the surface. The disk was rinsed with deionized 
water (5ml) in such a way that a layer of water remained on the disk.  
 
Figure 5.2 The setup for disk conditioning 
 
5.3.1.5   Extraction of sample 
Methanol (2.5 ml) and 50-ug ml-1 (50 µl) of internal standard were added to the water 
sample before extraction of the sample. The mixture was added to the extraction 
reservoir and filtered under vacuum. The flow rate of the filtration was maintained at 
5mL per min. The filtration top was removed from the filtration flask after the water 




The waste present in the reservoir flask was removed and cleaned. The resultant (eluent) 







Figure 5.3: Elution apparatus 
 
5.3.1.6   Elution of the sample 
Different solvents were used to elute the compounds attached to the disk. The sample 
bottle was rinsed and filled with acetonitrile (5ml). The disk was soaked in acetonitrile 
for 1 min followed by soaking of the disc in ethyl acetate for 1 min.  Both the eluents- 
acetonitrile and ethyl acetate were allowed to pass through sodium sulphate (3 gm) in 
order to remove any water present in the sample. Sodium sulphate is an inert drying 
agent that is able to remove suspended water in solvent or absorb about 20-25 % of 
water after mixing with ethyl acetate. The sample test tube and the sodium sulphate 
were rinsed twice with ethyl acetate (5 ml). The eluents were collected in a concentrator 
tube that was heated to 28oC in a heating block so that the volume reduced to 0.5 ml 
under nitrogen atmosphere. The eluents were transferred to sample vials and stored at 







5.3.2    Sample analysis with GC-MS 
Identification of 15 priority PAHs in the samples was confirmed by the retention time 
[RT] and abundance. The ion mass program used for quantification is detailed in Table 
5.3. A priority PAH (BaP) was utilized for the quantification using the response factors 
related to the respective internal standards based on 5-point calibration curve for PAH 
shown in Figure 5.4. The separation was accomplished in under 54 minutes on a 30 m, 
0.25 mm i.d. HP-5MS capillary column. In PAH measurements using GC-MS, the 
selectively of the column type was important to yield a good resolution for all PAHs 
compounds and also to improve peak shapes. In order to improve peak shapes and in 
order to have full understanding from the mass spectra, a short column type, tiny film 
thickness, and high operating temperature were required. The chromatogram of the 
individual compounds in the 15 PAHs compound mix is shown in Figure 5.5.  All PAH 
compounds could be clearly separated, where the first peak of Naphthalene eluted at 
6.67 min and the last peak of Benzo[ghi]perylene was at 40.49 min. The separation 
could be performed between PAH from the sample and its corresponding IS.  For 
example, the retention time of BaP compound from the sample was (35.31min) and its 
deuterated internal standards (39.90 min) that could be separated using the method. The 
peaks had been confirmed using their measured mass to charge ratio value given in 























4.22-8.06 Naphthalene Nap 2 128 6.67 
7.92-11.78 Acenaphthylene Acey 3 152 9.23 
8.06-12.35 Acenaphthene Acet 3 164 9.49 
11.77-14.05 Fluoren Flo 3 166 12.53 
12.15-17.70 Phenanthre Phe 3 178 14.07 
12.35-17.89 Anthracene Anth 3 178 14.76 
17.70-22.84 Fluoranthene Flan 4 202 18.20 
17.88-23.78 Pyrene Pyr 4 202 19.79 
22.84-29.34 Benz [a] anthracene B[a]a 4 228 25.23 
23.78-29.53 Chrysene Chry 4 228 27.57 
29.42-34.07 Benzo[b]fluoranthene B[b]f  5 252 32.50 
34.06-35.25 Benzo[k]fluoranthene B[k]f 5 252 34.48 
35.26-35.43 Benzo[a]pyrene B[a]p  5 252 35.31 
39.49-39.51 Dibenz[a,h]anthracene Ind 5 278 39.49 





Figure 5.4: Standard curves obtained GC-MS for BaP .A 30.0 m, 0.25 mm i.d. HP-5MS capillary column, 
Injection volume 5.0 ul, Injection temperature 250 0C. 
 
Figure 5.5 shows the mass spectrum or the total ion chromatogram for each compound 
on column.  Mass spectrum pattern for each PAH allows for a highly specific and 
sensitive method for quantitation of a PAH in the matrix. Because the 15 PAHs have 
different chemical properties and retention times, 6 internal standards (Naphthalene D8, 
1,4-Dichlorobenzene D4, Acenaphthylene D10, Phenanthrene-D10, Chrysene D12, 
Perylene D12) were used to monitor the PAHs.  

























 Figure 5.5: Chromatogram of the individual compounds in the 15 PAHs mix. Peak ID : (a) Nap, (b) 
Ace, (c) Flo, (d) Phe, (e) Anth, (f ) Flan, (g) Pyr, (h) B[a]a, (i) Chry,( j) B[b]f, (k)B[e]a, (l) B[k]f, (m) 
B[a]p, (n) Pery and (o) Ind.  
 
The total-ion chromatogram graph below shows the 6 internal standards cover the 15 
PAH and distributed along the chromatogram (Figure 5.6). Usually, every PAH 
compound has a deuterated PAH with a more or less similar RT, ionization efficiency, 
detector response, and interactivity as the analyte of interest (Table 5.4). The internal 
standard must be inert and does not show any reaction to PAH sample or solvent diluted 




Figure 5.6: The total ion chromatogram of the 6 internal standards. Peak ID: Naphthalene D8,1,4-
Dichlorobenzene D4, Acenaphthylene D10, Phenanthrene-D10, Chrysene D12, Perylene D12. 
 
Table 5.4: Internal Standard with number of rings, molecular mass, and retention time 
Internal Standard  
Compounds 





Retention Time [RT] 
(min) 
1,4-Dichlorobenzene D4 1 147.00 5.278 
Naphthalene D8 2 128 8.210 
Acenaphthylene D10 3 152 15.205 
Phenanthrene-D10 3 178 21.452 
Chrysene D12 4 228 33.588 











5.3.2.1 Response Factor (RF) and Relative Response Factors (RRFs) experiment: 
Calibration curves were constructed from 3 to 7 ug/ml (ppm) (Table 5.5). GC-MS could 
obtain the required high response to BaP with liner calibration curves when the peak 
area was plotted against the concentrations (Figure 5.7). Using the same conditions as 
obtained in the experimental section, the separation could be completed between a BaP 
compound from sample and its corresponding IS. IS comparison is a good quantification 
method where each PAH can be quantified against the most appropriate IS.  SI technique 
is a suitable way for calculating the ratio between the responses produced (peak area) 
and the concentrations of compound that generate the signal. In chromatography this 
ratio is defined as the Response Factor [RF]. 
RF= peak area (response) (A) / concentration(C) 
                                                                                (Equation 1)   
Where: A = integrated abundance of the quantitation ion of the analyte x A = integrated 
abundance of the quantitation ion internal is standard C = quantity of analyte injected 
in concentration units x C= quantity of internal standard injected in concentration units 
is. 
 
RRFA = Response factor x / Response factor is 
                                                                                                              (Equation 2)   
The response from the PAH (BaP) peak was compared to the internal standard.  This 
procedure corrected for minor variations in the injection volume. Samples were fixed 
mass of internal standard and, different masses of standard analyte (PAH). The 










Table 5.5: Calibration Curve with Internal Standard. 
  
      Figure 5.7: GC calibration curve of PAH with internal standard (Naphthalene D8, 1,4-
Dichlorobenzene D4, Acenaphthylene D10, Phenanthrene-D10, Chrysene D12, Perylene D12). 













1 3 5 0.60 53204875 1813679 0.034088 
 
2 4 5 0.80 53204875 2854252 0.053646 
 
3 5 5 1.00 53204875 4361052 0.081967 
 
4 6 5 1.20 53204875 5673043 0.106626 
 





5.3.2.2   Relative standard deviation (RSD)  
In order to achieve the optimal conditions of PAH (n=6) it was necessary to calculate 
the average and standard deviation of the PAH solutions and real sample (tap water) 
and the relative standard deviation of the retention times and the peak areas as indicated 
in Table 5.6. The % RSD was used to express the precision and repeatability of the 
assay. It found that the RSD of the retention times and the peak areas for both samples 
were less than 0.5 % for retention times and less than 1% for peak area, which was an 
acceptable result and express the precision.  
For the average results: 
 
   (Equation 3) 
 
 
For the standard deviation: 
 
 
                                                    (Equation 4) 
 
For the relative standard deviation: 
                                                            





The Average  = Mean =     Sum of Observations  
 













Table 5.6: The average and standard deviation of the PAH solutions and real sample (tap water) and the 
relative standard deviation of the retention times and the peak areas 
 
5.3.2.3   Spiked and recovery experiments:  
Sample spiking can provide method validation accuracy. The separation and 
quantification of BaP (PAH) in the spiked samples were carried out using the same GC-
MS conditions as the standard solutions. The spiked sample was run in triplicate (n=3). 
Table 5.7 shows the presence of the spiked internal standard in the water samples. A 




Avg ± SD 
of peak areas 
[PAHs in standard solution] 
               Avg ± SD 
of  retention times 
PAH in real sample 







    23264219 ±1879 
12327713 ± 2615 
24353818 ± 1560 
37601895 ± 3175 
50414877 ± 7286 
46499372 ± 6338 
 
5.26 ± 0.0213 
8.192 ± 0.0043 
15.183 ± 0.0024 
21.435 ± 0.0025 
33.577 ± 0.0011 



























Recovery of the spiked sample shows if the expected result can be measured accurately.  
If the recovered result differs significantly from the result expected, this can be a sign 
that some factor in the sample matrix can be causing a falsely depressed result. 90-120% 
recovery is generally considered valid.   
% Recovery = (amount of spike substance (recovered)) /                                   
(amount of substance originally taken (standard)) x100 %        (Equation 6)                           
 Table 5.7: The recovery percentages of spiked (IS) found in tap water sample. 
  
Figure 5.8: the total ion chromatogram of real sample (tap water). All the spiked ISs were found in the    



































There were no PAHs observed in the samples and the low recoveries were related to 
the number of PAHs rings. As stated in [17] the recovery method of PAHs family 
decreases according to the number of their aromatic rings. Sometimes the poor results 
may be due to the presences of interfering substances arising from handling before the 
extraction process. As reported by [18] the presence of suspended particular matter 
during transportation can decrease the recovery percentage for PAHs. Table 5.6 and 
figure 5.8 illustrate the spiked (IS) results in tap water. Based on the high recovery 
percentages of the 6 isotopes spiked in real sample before the extraction. It can be 
confirmed that the pre-treatment extraction was effective. As previously mentioned the 
GC-MS technique could detect at very low concentrations of PAHs. The 
electrochemical bio-immunosensors (SPEs and magnetic platform) illustrated a good 
performance and exhibited increased sensitivity compared to colorimetric 
immunoassay. Table 5.9 shows the comparison of the optical and electrochemical and 
GC-MS. 
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13.7 to 123 
GC-MS - - 3.0 µg/ml - 
 
5.3.3   Conclusions  
An analytical method for the detection of BaP (PAH) in tap water sample was 
developed using GC-MS. Findings revealed a low concentration of BaP. The alternative 
commonly used method for the quantitative analysis of PAH could be carried out using 
HPLC-florescence detection (FD). GC-MS is a powerful method for determining 
volatile compounds in a variety of sample.  The internal standards were spiked in the 
tap water sample before the extraction procedure. The mass spectrum of the internal 
standard was compared to the real sample. The method was applied to the tap water. 
The tap water was spiked with (6 compound mix internal standard) and good recovery 
was obtained in the range of 89 to 108 % (n=3). It can be concluded that this method 
was reliable and effective.  
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General Conclusions and 
























Pollution of PAHs in water environments has resulted in the advancement of new 
methods to obtain higher quality solutions to monitor this issue more effectively. 
Mixtures of PAHs exist in different matrices normally, which make them difficult to 
detect. Large-scale investigation has been carried out in the areas of PAH extraction, 
separation and detection. For the last few years, scientists have developed various 
methods of detection, depending on the properties of the compounds to be measured, 
for instance the amount of target, physicochemical characterization, etc. They are 
mostly focused on chromatographic procedures in combination with various detectors, 
such as, mass spectrometry and UV spectrophotometry. However, these procedures 
depend on expensive laboratory based-devices with additional cost needed to conduct 
the analysis. Chromatographic procedures are not suited to in-field evaluations and on-
line water monitoring. Immunoassay procedures are another proposed alternative for 
PAHs detection in water monitoring. Immunoassay procedure is designed to determine 
specific chemicals by screening the compounds response to specific antibodies. This 
procedure has been broadly used in the field of clinical science. Recent developments 
have seen its uses extended to areas, for instance detection of chemicals in the 
environment. Electrochemical enzyme immunoassay format offers the advantages of 
specificity and sensitivity compared with other enzyme immunoassay detection 
methods. Moreover, electrochemical enzyme immunoassay introduced miniaturized 
system that allows for easy and low cost and volume required. There are a number of 
solid supports (transducers) that have been used in electrochemical format detection 
including amperometric and voltammetric. These electrochemical transducers are used 






In this project, a portable electrochemical system based on an integrated lab on a chip 
platform consisting of (a) Microfluidic cartridge with immunosensor (b) Fluidic 
manifold with valves to control fluid (c) Control module, containing interfaces for 
microfluidics, immunosensor and user display has been described. The immunosensor 
was fabricated in a three-electrode system (working, counter and reference electrodes) 
at Tyndall national institute. This sensor was configured in a multi-electrode array 
screening for real time environmental measurements. This microfluidic platform 
allows quick time and portable measurement and requires only small volumes of 
sample. Modification of the immunosensor array surface could enhance the binding of 
the target to its specific antibody, thus increasing the sensitivity of the sensor towards 
environmental pollutants. Preliminary result on sample was conducted using this 
platform. However, no further studies were carried out to optimise the parameters and 
to develop the sensitivity as the timeframe of the research study, it was difficult to 
acquire quantitative data for standard and real samples. Optimisation experiments on 
different format components were performed in order to achieve the ideal conditions 
for a maximum immunoassay binding. Even though the tests for optimisation of 
solvents used to dilute PAHs were not performed for the assay using electrochemical, 
it has been considered that DMSO is the optimal solvent for the best organic solvents. 
This consideration was made based on the tests conducted for the optimisation of 
organic solvent using optical detection. This consideration was also supported by [1], 
where it has been reported that the use of DMSO to dilute PAHs for their 
electrochemical screen-printed-electrode resulted in a good assay performance. The 
displacement assay format used in this project could be of interest for individual 
targeted compounds (BaP). A key aspect in an immunosensor development is to 





 In order to enhance the sensitivity of the developed immunosensor, the working 
electrode was modified with the 11-MUA SAM. Activation of water-soluble 
carbodiimide was performed using EDC and NHS before the antibody immobilisation. 
The performance of 11-MUA SAM in ethanolic solution has been demonstrated as a 
result to improve the binding of the antibody towards the surface for the detection of 
BAP in the water samples. Characterisation of the 11-MUA formations on the 
immunosensor surface was carried out using cyclic voltammetry (CV) and contact 
angle measurements. The results confirmed that with the presence of 11-MUA 
formations on the immunosensor surface, the immobilisation of antibodies to the chip 
was improved and thus the sensitivity of the sensor increased. In this project, another 
electrochemical method for PAHs detection was that based on the screen-printed-
electrode and nanoparticles as the solid surfaces were also developed. Screen- printed- 
electrode and nanoparticles were able to detect PAH analytes and also provide 
quantitative analysis. The electrochemical methods with an immunoassay principle 
showed a limit of detection (0.07 ng/ml) and a linear range (1 to 10 ng/ml). 
Displacement assay was carried using optical immunoassay for determination of 
benzo[a]pyrene in water. However, there was no benzo[a]pyrene was detected. 
Spiking of 5 and 50 ng ml of benzo[a] pyrene showed high percentages of in each 
sample, indicating that our system was actually working. As this system was unable to 
detect the benzo[a]pyrene without spiking was probably because of the very low 
amount of benzo[a]pyrene presence in the samples, or might be no presence of 
benzo[a]pyrene in the water at the time the samples were collected. These results were 







To validate the developed immunosensors, Gas Chromatography-Mass Spectrometry 
was carried out for determination of PAHs in tap water. GC-MS is one of the promising 
traditional techniques for detection of PAHs in different sample matrices. Analysis of 
tap water samples showed high percentages of recovery in tap water sample and there 
was no presence of PAHs. GC-MS analysis indicated that the system was actually 
working. In general, the up-and-coming performance of the developed electrochemical 
system could satisfy the need of excellent biosensors. However, these developed 
systems will not replace standard methods for the detection of PAHs, but will rather 
complement them. 
 
6.2   Suggestions for Future perspective  
 
The challenges throughout the tests were maintained. Our immunosensors array could 
be re-used, by cleaning the chips with the protocols that was optimised in Chapter 4. It 
was great to improve the regeneration of the chip, thus it could be used for multiple 
times. To date, gold materials have been used in the most studies as sensing material 
because of their favorable properties, including electronic property and easy surface 
modifications. However, researches on indium tin oxide could be considered for 
quantitative immunoassay applications as this thin film material provides a good 
electrical conductivity, electrochemical potential window, and high optical 
transparency [2]. According to Aziz et al., this thin film material was used in 
immunosensor, in which it has been successful in developing a platform based on 
indium tin oxide to detect mouse IgG with a LOD of 1.0 pg/ml [3].  Finally, the serious 
challenge associated with any environmental assay is the treatment of interferences. 
Interferences affect the read-out values and lifetime of the system. The simple and low 





could be easily implemented to increase lifetime of the system. Environmental 
monitoring still faces various challenges, table 6.1 representing the feasibility of 
printing technologies that can be used to overcome them.   
 











Metals (oxidant condition) Conductive polymer  
Stability Reactants involved                
(low stability) 
Avoid using biomolecules 
due to their bioactivity and 
capability decrease 
drastically in environment 
conditions 
Energy supply  Battery Photovoltaic cell 
Production cost Traditional fabrication 
used to produce 
deployable devices is 
costly  
Printing technologies used to 
produce deployable devices 
for analytical purposes is 
low cost  
 
It is obvious that unaddressed technologies gaps could be filled in the near future with 
3D printing technology and ink printing. Printing technologies will not only solve the 





produce full deployable devices at low cost. LOC system will excel as promising 
miniaturized platform for in situ and real time monitoring of pollutants.      
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